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 Intrauterine infection with the oral commensal anaerobe Fusobacterium nucleatum has been 
associated with adverse pregnancy outcomes. We have previously established a mouse model to study 
the mechanism of hematogenous F. nucleatum leading to fetal and neonatal death. Here, we report that 
Toll-like Receptor 4 (TLR4) from the maternal rather than paternal, and endothelial rather than 
hematopoietic cells mediate placental inflammation, especially the production of the proinflammatory 
cytokine interleukin-1 beta. Downstream of TLR4, a spatiotemporal pattern of the transcription factor NF-
kB activation was observed spreading from the decidual endothelium to the surrounding 
spongiotrophoblasts within the first six hours of infection. Maternal TRIF, an adaptor protein downstream 
of TLR4 pathway, but not NLRP3, a cytosolic signaling receptor that constitutes inflammasome complex, 
mediated the fetal and neonatal death.  
In an effort to find a prophylactic preventive method against the detrimental birth outcome induced 
by F. nucleatum placental infection, omega-3 fatty acids were tested for their anti-inflammatory properties. 
Omega-3 oil supplementation in pregnant mice inhibited the transcription and release of inflammatory 
cytokines, prevented fetal and neonatal death, and also suppressed the proliferation of F. nucleatum in the 
placenta. Moreover, omega-3 supplementation was shown to enhance neutrophil recruitment to the site of 
infection. However, omega-3 supplementation did not protect the pregnancy from Listeria monocytogenes 
infection in vivo, despite the in vitro results where inflammation induced by both Gram-negative and Gram-
positive bacteria were suppressed by omega-3 fatty acids.  This study presents the first direct evidence of 
maternal, rather than fetal, signal leading to adverse pregnancy outcome, and suggests an exciting 
therapeutic potential of dietary omega-3 fatty acids. 
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Chapter 1: Introduction 
 
Overview 
This chapter is aimed to provide a comprehensive background to understand the idea linking oral 
bacteria to the pathological events leading up to adverse pregnancy outcomes. First, the current 
understanding of periodontal disease contributing to systemic disease in general will be discussed. Next, 
the way pregnancy alters the susceptibility of an individual to periodontal disease and its consequences in 
the pregnancy outcomes will be reviewed. Finally, the pathogenic mechanisms of oral bacteria in adverse 
pregnancy outcomes will be reviewed.  
 
The human oral microbiome 
 The human oral cavity harbors over 700 bacterial species, the second most diverse human 
microbiome after that in the gut (Kilian, 2018).  The oral biofilm consists of early commensal colonizers 
such as Streptococci spp and Actinomyces spp, and secondary and late colonizers such as Fusobacterium 
nucleatum, Porphorymonas gingivalis, Tannerella forthysia, and Treponema spp (Huang et al., 2011). In 
1998, Sigmund Socransky classified the oral bacterial species into five complexes based on their role in 
the initiation and progression of chronic periodontal disease (Socransky et al., 1998). Species of the “red” 
complex, i.e. P. gingivalis, T. forthysia, and T. denticola, are strongly associated with symptoms of 
periodontitis, and are the last to appear in the biofilm. Those of “orange” complex including F. nucleatum, 
Prevotella intermedia, Prevotella nigrescens, Parviomonas micra, and Campylobacter spp.   show a milder 
association with clinical parameters of periodontal disease and mediate the red complex species to 
colonize. The rest, “yellow,” “green,” and “purple” complexes consist of early colonizers typically isolated 
from periodontal healthy sites. The transition from a homeostatic to a dysbiotic microbiota, resulting from 
an increased mass of the red and orange complex bacteria, typically leads to host immune responses that 






 Periodontal disease is a chronic infectious disease consisting of two stages, the mild form of 
gingivitis and the advanced form of periodontitis. Progression from gingivitis to periodontitis involves 
worsening of gingival inflammation and destruction of tissue and bones surrounding the teeth (Chapple et 
al., 2015; Kinane, 2001). Periodontitis affects half of the adults over 30 years old in the U.S. (Eke et al., 
2012). Etiology of periodontal disease at the microbial level has been attributed to dysbiosis of the oral 
microbiome. At the host level, race, ethnicity, socioeconomic factors, as well as behavioral factors such as 
smoking or alcohol consumption are proposed to be important risk factors (Petersen and Ogawa, 2012). 
According to National Health and Nutrition Examination Survey in 2009-2012, the prevalence of 
periodontitis were higher in Hispanic (63.5%) and non-Hispanic Black (59.1%) adults than in non-Hispanic 
Whites (40.8%), and that of current smokers (68.7%) was almost double of that of non-smokers (36.8%) 
(Eke et al., 2015). 
 
Periodontal disease and systemic diseases 
Periodontopathogens not only affect the tissue homeostasis and health of the oral cavity but also 
those of distal organs. It was first suggested by Willoughby Miller’s “focal infection” theory that oral bacteria 
of periodontally diseased individuals serve as a reservoir of migrating microbes responsible for systemic 
infection (Miller, 1880). Since then, the relationship between periodontal disease and systemic disease has 
been a subject of debate amongst the dentists and physicians (Ameet M et al., 2013). Epidemiological 
studies support that periodontal disease status is associated with an increased risk of cardiovascular 
disease (Janket et al., 2003; Mustapha et al., 2007), rheumatoid arthritis (RA) (Chen et al., 2013; Tang et 
al., 2017), neurodegenerative disorders (Sheu and Lin, 2013; Singhrao et al., 2014), and pregnancy 
complications (Jeffcoat et al., 2001; Offenbacher et al., 1996). Bacteria of oral origin have been detected 
at various extra-oral sites associated with infections and inflammations(Han and Wang, 2013). Direct 
evidence of both DNA and live culture of periodontopathogens as well as their proteins have been found in 
various locations such as atherosclerotic plaque (Cavrini et al., 2005; Haraszthy et al., 2000; Kozarov et 
al., 2005), neurodegenerative brain such as that of Alzheimer’s disease (Dominy et al., 2019; Itzhaki et al., 
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2004; Poole et al., 2013), and feto-place ntal unit of pregnant women with adverse pregnancy 
outcomes(Gonzales-Marin et al., 2013; Han et al., 2006, 2009, 2010; León et al., 2007; Wang et al., 2013).  
 
Periodontal health during pregnancy 
Before discussing how periodontal disease affects pregnancy, it is relevant to review how 
pregnancy status affects women’s periodontal health. The dynamic changes in a woman’s body during 
pregnancy increase her susceptibility to and progression of periodontal disease (Gürsoy et al., 2008; Patil 
et al., 2012; Silva de Araujo Figueiredo et al., 2017; Vogt et al., 2012; Wu et al., 2015). For example, 
pregnancy gingivitis, as the term suggests, refers to the condition of the gingiva being prone to swelling, 
bleeding and inflammation that peaks in second or third trimester, which then subsides within 3 months 
postpartum (Gursoy et al., 2008; Tilakaratne et al., 2000; Yalcin et al., 2002). Several factors have been 
proposed for the enhanced prevalence of gingivitis in pregnant women: the increased level of sex 
hormones, the suppressed immune system, and the shifted oral microbial composition.  
Prevalence of transient gingivitis is increased not only in pregnant women but also in ovulating and pre-
menstrual individuals, and declines during menstruation, suggesting a role of female sex hormones (Lapp 
and Lapp, 2005; Machtei et al., 2004). A dramatic increase in female sex hormones alters an individual’s 
immune system affecting the progression of gingival inflammation (Mealey and Moritz, 2003). For example, 
the increased levels of progesterone and estradiol have been shown to enhance production of 
prostaglandin E2 (PGE2), an inflammatory mediator, in the gingival tissues (Figuero et al., 2010; 
Mascarenhas et al., 2003; Miyagi et al., 1993). In turn, the increased PGE2 in gingival epithelium contributes 
to the vasodilatation, vascular permeability and bone resorption during periodontal disease, correlating to 
the level of gingival inflammation (Mascarenhas et al., 2003; Yalcin et al., 2002).  
The altered immune defense mechanisms during pregnancy may also contribute to the worsening of 
periodontal conditions due to lack of suppression of pathogenic microflora (Gürsoy et al., 2010; Silva de 
Araujo Figueiredo et al., 2017). Progesterone and estrogen have also been suggested to shift the oral 
microenvironment more favorably to periodontopathogens, evidenced by a dominance of 
periodontopathogens in the oral microbiome during pregnancy and the return of healthy flora postpartum 
(Balan et al., 2018; Carrillo-de-Albornoz et al., 2010).  
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Furthermore, while poor oral hygiene has been associated with higher prevalence of periodontal disease, 
the association is more pronounced in pregnant women (Carrillo-de-Albornoz et al., 2012; Kashetty et al., 
2018; Vogt et al., 2012). A recent experimental animal study has shown that oral infection with the same 
dose of P. gingivalis, a periodontopathogen, induced higher gingival inflammation and bone loss in pregnant 
than control mice (Duan et al., 2018). These findings suggest that pregnancy renders one more susceptible 
to periodontal disease .   
 
Adverse pregnancy outcomes (APO) 
APO encompass a broad range of events such as preterm birth (PTB), preeclampsia, eclampsia, 
stillbirth, neonatal sepsis, low birth weight and maternal and perinatal mortality. The different forms of 
adverse outcomes have multiple shared etiologies and are not mutually exclusive. For example, PTB, 
defined as birth before 37 weeks of gestation, is often accompanied by low birth weight, may lead to 
neonatal mortality and mobidity, and may be preceded by preeclampsia. PTB has received the most 
attention due to its global prevalence of over 10% and its health and financial burden to the surviving 
individual, the family, as well as the society (Howson et al., 2013). PTB is a leading cause of infant mortality 
accounting for 35% infant deaths in the U.S. (Callaghan et al., 2006; Matthews et al., 2015). It can also 
result in serious neonatal complications such as respiratory distress syndrome, intraventricular 
hemorrhage, and necrotizing enterocolitis (Chawanpaiboon et al., 2019; Liu et al., 2012). Spontaneous PTB 
that are not medically indicated accounts for up to 75% of all PTB and the risk factors include young 
maternal age, high body-mass index, multiple pregnancies in short intervals, pre-existing disease, family 
history and infection (Goldenberg et al., 2008; Romero et al., 2014). Nearly 80% of PTB has occurred in 
underdeveloped Asia and sub-Saharan Africa in 2014 (Chawanpaiboon et al., 2019), but PTB rate in 
developed country are not diminishing either. PTB rate in the U.S. has been rising by 1% for the third 
straight year in 2017 (Martin and Osterman, 2018). Prediction of PTB after 34 weeks depends on 
sonographic diagnosis of short cervix, and for those diagnosed, prevention strategies such as vaginal 
administration of progesterone and cervical cerclage have been effective (Romero et al., 2012). However, 
transvaginal cervical length does not predict PTB before 34 weeks, low birthweight, or maternal or fetal 
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infection, leaving the majority of women at risk without a diagnostic or preventive method (Berghella et al., 
2013).  
The physiological events that occur during preterm labor is not so much different from term labor, 
including uterine contraction, cervical dilation and the rupture of chorioamniotic membranes, all cued by the 
shift from anti-inflammatory to pro-inflammatory chemokines and cytokines in the myometrium. The 
difference lies in that PTB is initiated by pathological pathways such as intrauterine infection and the 
subsequent inflammation (Romero et al., 2014). Despite the multifactorial etiology, the association between 
PTB and infection has been well accepted. Intrauterine infection with or without preterm premature rupture 
of membrane (PPROM) has been reported to account for at least 25-40% of PTB by traditional culturing 
techniques alone (Andrews et al., 1995; Goldenberg et al., 2008; Rouse et al., 2004). The rate of intrauterine 
infection is inversely related to gestational age at birth, with histologic evidence of chorioamnionitis reported 
to be nearly 70% in preterm deliveries between 20 to 24 weeks, whereas only 16% after 34 weeks (Lahra 
and Jeffery, 2004; Yoon et al., 2001). Chorioamnionitis refers to inflammation in the chorion and amnion, a 
significant indication of infection (Kim et al., 2015; Peng et al., 2018). Due to the confusion resulting from 
the broad implication in clinical management of the term chorioamnionitis, the National Institute of Child 
Health and Human Development, Society for Maternal Fetal Medicine, American College of Obstetrician 
and Gynecologist and American Academy of Pediatrics came up with a new terminology, “Triple I,” for 
“intrauterine infection or inflammation or both” (Higgins et al., 2016). While there are not many studies under 
the new terminology, chorioamnionitis with implied infection produces bacterial endotoxins and 
proinflammatory cytokines, inducing the physiological events of labor and delivery (Galinsky et al., 2013). 
When left untreated, the fetuses or neonates may develop fetal inflammatory response syndrome (FIRS) 
that leads to bronchopulmonary dysplasia, early hypotention, and even death (Francis et al., 2019). 
Additionally, while rupture of membrane is a normal part of the parturition, intrauterine microbial invasion 
causes an inflammatory cascade to biochemically induce PPROM and cervical ripening, eventually leading 
to PTB (Pararas et al., 2006). Maternal extrauterine infections such as pneumonia (Graves, 2010) and 




Periodontal disease and APO 
Periodontal disease during pregnancy affects the gestational length as well as maternal and fetal 
health (Ide and Papapanou, 2013; Offenbacher et al., 2006; Sanz et al., 2013; Scannapieco et al., 2003; 
Xiong et al., 2006). The Offenbacher group was the first to report a positive association between periodontal 
disease and PTB, followed by several more observational studies relating to PTB, preeclampsia and low 
birth weight (Offenbacher et al., 1996; Boggess et al., 2003; Jeffcoat et al., 2001; López et al., 2002). Since 
then, numerous studies have associated periodontal disease with APO (Cobb et al., 2017; Ide and 
Papapanou, 2013; Sanz et al., 2013; Xiong et al., 2006). A recent analysis of 23 systematic reviews on the 
subject including a total of 120 individual primary studies concluded that “with caution in terms of causality, 
they appear to indicate that periodontal disease during pregnancy contributes importantly to the overall 
risks of preterm births, LBW, and preeclampsia.”(Daalderop et al., 2018). 
Multiple guidelines and statements have been published recommending that pregnant women 
receive professional oral health care for the possible benefits for maternal and fetal health (American 
College of Obstetricians and Gynecologists Women’s Health Care Physicians and Committee on Health 
Care for Underserved Women, 2013; Council on Clinical Affairs, 2016; Oral Health Care During Pregnancy 
Expert Workgroup, 2012; U.S. Department of Health and Human Services, 2000). Yet, periodontal care is 
not a part of routine perinatal care due to lack of consensus regarding the benefits of periodontal treatments 
in pregnancy outcomes (Fiorini et al., 2013; Iheozor-Ejiofor et al., 2017; Kaur et al., 2014; Rosa et al., 2012; 
Srinivas and Parry, 2012). A Cochrane review on the effect of periodontal therapy on preventing APO have 
concluded that due to poor quality and design of the currently available randomized control trials, there is 
insufficient evidence to either prove or disprove the hypothesis (Iheozor-Ejiofor et al., 2017). In fact, results 
from clinical intervention trials on various systemic diseases have thus far been controversial, failing to 
achieve a consensus in whether periodontal treatment can improve parameters of such diseases (Abbayya 
et al., 2015; Cobb et al., 2017; Han, 2015; Hill, 1998; Ide and Linden, 2014; Kamer et al., 2008; Leishman 
et al., 2010; Li et al., 2000; Lockhart et al., 2012; Newnham et al., 2009; Nguyen et al., 2015; Sabharwal et 
al., 2018; Slocum et al., 2016; Srinivas and Parry, 2012). The lack of efficacy of the intervention studies 
could be due to the inconsistencies of patient population recruited with regard to the disease severity, the 
mode of intervention, the timing and number of treatments, and whether or not the treatments led to 
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resolution of inflammation (Han, 2011). Indeed, the definition and measurements of periodontal disease 
have varied widely across different studies. Due to lack of standard diagnostic criteria for periodontal 
disease, studies have either base on degree of probing depth, clinical attachment levels, a combination of 
the two, or other measures such as decayed or missing teeth (Manau et al., 2008; Xiong et al., 2006). A 
secondary analysis study of 23 publications have reported that the definition of periodontitis directly affects 
the association between periodontitis and APO, and that this may explain the lack of consensus on this 
topic (Manau et al., 2008). Similarly, measurements of outcomes varied as well. The methods to assess 
birth weight and gestational age are seldomly reported, which may lead to a significant bias in interpretation 
of the pregnancy outcomes (Vettore et al., 2006). Finally, confounding risk factors such as maternal age, 
socioeconomic status, body mass index, stress, pregnancy history and infections are often insufficiently 
controlled for (Xiong et al., 2006). Rather than a generalized procedure, a thorough assessment and care 
of individual periodontal health may be beneficial to the pregnancy outcome. In addition, in light of the 
recent understanding of the mechanism by which periodontopathogens cause APO, new prevention and/or 
treatment strategies beyond the conventional periodontal therapy may be necessary. 
 
Mechanisms underlying the link between periodontal disease and APO 
Proposed mechanisms regarding periodontal disease as a trigger of APO include either the indirect 
transmission of inflammatory signals from the oral cavity or the direct bacterial migration (Hajishengallis, 
2015; Han, 2015). Locally produced inflammatory mediators such as bacterial products, proinflammatroy 
cytokines, or C-reactive protein (CRP) may disseminate through the circulation from the periodontally 
diseased sites, indirectly eliciting the release of inflammatory cytokines and prostaglandins in the feto-
placental unit, leading to uterine contraction and rupture of fetal membranes (Andrews et al., 1995; 
Goldenberg et al., 2000). Indeed, PTB patients are reported to have higher prevalence of periodontal 
disease, accompanied by increased levels of serum proinflammatory cytokines and prostaglandins, 
suggesting that periodontal disease may result in adequate inflammatory signals to trigger early labor and 
delivery (Latorre Uriza et al., 2018; Perunovic et al., 2016). Similarly, elevated CRP has been reported in 
pregnant women with periodontal disease who developed PTB and/or preeclampsia cases (Herrera et al., 
2007; Horton et al., 2008). Furthermore, elevated or reduced fetal and maternal immunoglobulins against 
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oral pathogens such as Campylobacter rectus, P. gingivalis, T. forsythia, and T. denticola in PTB patients 
have been suggested as an indirect evidence of periodontal infection leading to APO (Ebersole et al., 2009; 
Madianos et al., 2001). However, confounding risk factors, especially other inflammatory disease such as 
cardiovascular disease or diabetes, deem it challenging to deduce a causative role of the inflammatory 
signals from periodontal disease alone. 
A better-supported mechanism is the direct transmission of periodontopathogens from the oral 
cavity to the intrauterine cavity through the hematogenous route. Transient dental bacteremia is a frequent 
event that can occur by routine oral care procedures such as tooth brushing (Kinane et al., 2005; Lockhart 
et al., 2008). In patients with periodontal disease, the number of oral bacteria reaching the circulation 
increases from two- to ten-fold compared to healthy controls (Marín et al., 2016). Pregnancy-induced 
gingivitis, gingival vascularization, vascular permeability, and changes in oral biofilm composition (Balan et 
al., 2018; Kruse et al., 2018; Mariotti and Mawhinney, 2013; Wu et al., 2015, 2016) all contribute to an 
increased chance of dental bacteremia during pregnancy. Once in the circulation, certain adhesion proteins 
of the periodontal pathogens have been characterized to bind and penetrate the host cells (Bélanger et al., 
2012; Han et al., 2000, 2005; Olsen and Progulske-Fox, 2015; Sheen et al., 2010; Tenenbaum et al., 2005; 
Weinberg et al., 1997). In turn, colonization of the feto-placental unit has been shown to lead to APO via 
inflammation (Garcia-So et al., 2019; Han et al., 2004). 
 
Oral bacteria in APO 
The association between periodontal disease and APO has been supported by direct detection of 
oral bacteria in the intrauterine cavity. Intrauterine infection is generally believed to be caused by bacteria 
ascending from the vaginal tract, which colonize the fetal membranes, amniotic fluid, and the decidua 
(Goldenberg et al., 2000; Kemp, 2014). Some frequently isolated species from the amniotic fluid of women 
with intra-amniotic infection include F. nucleatum, Ureaplasma spp., Gardnerella vaginalis, Bacteroides 
spp., Porphyromonas spp., and Peptostreptococcus spp. (Dingens et al., 2016; Han et al., 2009, 2010; 
Wang et al., 2013; Wong et al., 2018; Goldenberg et al., 2000). However, some of these bacteria, e.g. F. 
nucleatum, do not originate from the vaginal tract, but rather, are of oral origin (see below). As discussed 
earlier, pregnancy creates a favorable oral environment for the periodontopathogens and also increase 
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one’s susceptibility to gingival inflammation (Kashetty et al., 2018). Periodontopathogens that are increased 
in volume during pregnancy are postulated to gain access to the fetoplacental unit by hematogenous route 
and have been associated with adverse pregnancy outcomes such as PTB (Han and Wang, 2013; Xiong 
et al., 2006).  
The first evidence of oral bacteria invading into the intrauterine cavity was reported by Han et al , 
in which uncultivated oral Bergeyella was concurrently detected in the amniotic fluid and maternal 
subgingival plaque in a case of PTB (Han et al 2006). Han et al. subsequently reported detection of bacterial 
DNA of uncultivated or difficult-to-cultivate species such as F. nucleatum, Sneathia spp., Bergeyella sp., 
Peptostreptococcus sp., and Bacteroides spp. in amniotic fluids associated with PTB (Han et al., 2009), as 
well as the presence of F. nucleatum, Bergeyella, and Sneathia sanguinegens in the matching amniotic 
fluid and cord blood associated with early-onset neonatal sepsis (Wang et al., 2013). 
The most prevalent oral bacterial species implicated in APO is by far F. nucleatum (Gonzales-Marin 
et al., 2013; Han, 2011; Han et al., 2009, 2010) (see below). A number other oral species have also been 
linked to APO. Capnocytophaga sputigena has been reported in several cases of early PTB (<32 weeks), 
cultivated from the infant gastric fluid, tracheal aspiratate and blood, as well as the cervix, placenta, amniotic 
fluid, and the endometrium (Douvier et al., 1999; Lopez et al., 2010; Mekouar et al., 2012). Sneathia, 
Leptotricha and Peptostreptococcus species have been detected in preeclampsia patients by PCR-based 
technique (DiGiulio et al., 2008). Multiple groups have reported P. gingivalis DNA and histological presence 
in the amniotic fluid and placenta of PTB or preeclampsia patients (Barak et al., 2007; Katz et al., 2009; 
León et al., 2007).  
  Mechanisms of oral microbes in APO have been studied using animal models. The Offenbacher 
group established an experimental model by inoculating P. gingivalis in a subcutaneous chamber or 
intravenous injection in pregnant hamsters and reported fetal growth restriction, increased embryo lethality 
and resorption, and release of inflammatory cytokines (Collins et al., 1994a, 1994b). Their chronic murine 
infection model also resulted in fetal growth restriction and T cell-mediated inflammation, and translocated 
bacteria was detected by PCR in the liver and the uterus (Lin et al., 2003). The Takata group established a 
chronic dental infection model, also using P. gingivalis, by directly infecting the molar pulp chamber of 
pregnant mice 6 weeks prior to mating, which resulted in PPROM, inflammation and immune cell infiltration 
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in the placental tissues, and PTB (Ao et al., 2015). With this model they identified an immune regulator, 
Galectin-3, that mediates NF- B inflammatory pathway leading to PTB in mice (Miyauchi et al., 2018). The 
Han group, in contrast, established an acute infection model of hematogenous infecting pregnant mice with 
F. nucleatum, resulting in placental colonization, inflammation and fetal death through TLR4/NF- B 
activation in the maternal endothelial cells (Garcia-So et al., 2019; Han et al., 2004; Liu et al., 2007) (see 
below). This model well corroborates with a human stillbirth case caused by acute intrauterine F. nucleatum 
infection (Han et al, 2010).  
 
Fusobacterium nucleatum 
F. nucleatum is a Gram-negative, anaerobic, filamentous and a core commensal microbe in the 
human oral cavity (Abusleme et al., 2013; Bolstad et al., 1996). It has long been associated with the 
development of periodontal disease, and more recently with infectious and inflammatory diseases in distal 
organs (Han, 2015; Hajishengallis, 2015). Several characteristics of F. nucleatum have been attributed to 
how the commensal organism becomes pathogenic: first, its predominant presence in both healthy and 
diseased oral sites; second, its essential role in forming dental plaque through coaggregation with other 
microbes; and last, its ability to adhere to and invade host cells (Bradshaw et al., 1998; Han et al., 2000; 
Moore and Moore, 1994; Whittaker et al., 1996).  
F. nucleatum can be detected in infants’ oral cavity as early as 2 months of age as the most common 
obligate anaerobe, and is found in plaques sampled from healthy and periodontal disease sites at all ages 
(Könönen et al., 1999). The mass of F. nucleatum in the oral cavity increases during periodontal disease in 
correlation with the “red” complex bacteria (Socransky et al., 1998). In fact, F. nucleatum is known to 
coaggregate with a wide range of bacteria and can bridge the early and late colonizers of the dental biofilm 
by creating a suitable growth platform for obligate anaerobes in aerobic environment (Bradshaw et al., 
1998; Kolenbrander et al., 2002). The coaggregation characteristic of F. nucleatum is due to its adhesins 
such as Fap2, RadD and Aid1 (Kaplan et al., 2014, 2010; Kolenbrander, 2000; Weiss et al., 2000). Another 
adhesin, FadA (Fusobacterium Adhesin A), is well characterized for its ability to bind and invade host cells, 
and in particular, has been shown to permeabilize the endothelium, allowing F. nucleatum, as well as other 
microbes, to enter the circulation and reach distal organs outside the oral cavity (Fardini et al., 2011; Han 
11 
 
et al., 2005). In combination, these adhesins enable F. nucleatum to bring with it otherwise non-invasive 
oral commensals across the host endothelium and epithelium to induce host immune responses (Edwards 
et al., 2006; Fardini et al., 2011; Kaplan et al., 2010). In support of this, animal studies have revealed that 
polymicrobial infection with F. nucleatum is more potent in biofilm formation and dissemination, and eliciting 
host immune responses, compared to that without F. nucleatum, highlighting the key role this 
microorganism plays in periodontal disease-induced systemic complications (Rivera et al., 2013; Settem et 
al., 2012). 
In vitro studies have revealed that F. nucleatum may trigger the production of a range of 
inflammatory cytokines such as IL1 , IL6, IL8, and tumor necrosis factor alpha (TNF- ), or 
metalloproteinases (MMPs) (Gursoy et al., 2008; Han et al., 2000; Kaplan et al., 2010; Rubinstein et al., 
2013). Metabolites such as butyrate, propionate, and ammonium ions are produced by F. nucleatum in 
periodontal plaques and can contribute to the destruction of host tissues depending on their concentrations 
(Ochiai and Kurita-Ochiai, 2009). F. nucleatum is unique in that not only does it possess the virulence 
factors that can stimulate the host response locally, but also enable the systemic dissemination of itself and 
other periodontal pathogens to cause infection and inflammation at extra-oral sites. 
Early evidences of F. nucleatum in patients with APO was based on cultivating the bacteria from 
the amniotic fluid of PTB patients (Miller et al., 1980; Watts et al., 1992; Weible and Randall, 1985). With 
the advancement of 16S rRNA gene-based culture-independent technologies, F. nucleatum have been 
detected in the placenta (Blanc et al., 2015; Chan et al., 2019; Doyle et al., 2014), amniotic fluid (Bearfield 
et al., 2002; Ercan et al., 2013; Gardella et al., 2004; Han et al., 2009; Wang et al., 2013), fetal membrane 
(Cahill et al., 2005), and neonatal gastric samples (Gonzales-Marin et al., 2013) of PTB cases, as well as 
placentas of hypertension (Swati et al., 2012) and preeclampsia (Barak et al., 2007) cases. Although 
detection of microbes does not prove a causal effect, a metagenomic study showed that the relative 
abundance of F. nucleatum was significantly increased in placentas of patients with PTB and severe 
chorioamnionitis than in term pregnancy (Prince et al., 2016). It is now well accepted that F. nucleatum 
detected in the fetoplacental unit of APO originates from the oral cavity, having been detected concurrently 
in the mothers’ (or their partners’) oral cavities and the placentas (Swati et al., 2012), amniotic fluids (Ercan 
et al., 2013; Gauthier et al., 2011), neonatal gastric samples (Gonzales-Marin et al., 2013), or even stillborn 
12 
 
fetus (Han et al., 2010). Several studies have reported that increased abundance of F. nucleatum in the 
oral cavity increases the chance of detecting F. nucleatum in the placentas. Higher subgingival levels of F. 
nucleatum were detected in pregnant women with high risk for PTB than in non-pregnant group (Kruse et 
al., 2018). It is also detected more frequently in the placentas of PTB women with periodontitis than from 
full-term women without periodontitis (Blanc et al., 2015).. 
An animal model of F. nucleatum infection in pregnancy has been established to illustrate its causal 
effects on APO. When F. nucleatum was introduced into a pregnant mouse by the tail vein, F. nucleatum 
colonized the placenta and led to fetal and neonatal death (Han et al., 2004). Figure 1.1 shows the bacteria 
in the endothelium of the mouse placenta (Han et al., 2004). The group further showed that F. nucleatum 
utilizes its FadA adhesin to bind and invade the endothelium of the placenta (Ikegami et al., 2009), and that 
the colonization and proliferation of F. nucleatum was limited to the placenta and not sustained systemically 
in the liver or spleen, demonstrating organ specific nature of the infection (Han et al., 2004). Recently we 
pinpointed the endothelial cells in the maternal decidua as the origin of inflammation. In agreement with the 
hematogenous origin of the infection and the spatial confinement of the bacterial colonization to the 
decidua, our results demonstrated that the inflammatory response followed the initial activation of TLR4-
NF  B pathway in the decidual endothelium and expanded to the nearby cells (Garcia-So et al., 2019). 
Moreover, we showed that ingestion of omega-3 fatty acids throughout the gestation suppresses not only 
placental inflammation but also bacterial proliferation thus improving the fetal and neonatal outcome. 
Although F. nucleatum is injected directly into the blood stream in this model, its hematogenous 
dissemination from the oral cavity to organs such as heart, liver, kidney and lung has been shown in non-
pregnant mice (Chukkapalli et al., 2015; Velsko et al., 2015). Therefore, F. nucleatum from the oral cavity 




 The association between periodontal disease and APO has been demonstrated by numerous 
epidemiological studies. Investigation into the causal relationship and possible underlying mechanisms is 
available but scarce. Periodontal disease, hallmarked by the shift of microflora to dysbiosis and the 
13 
 
presence of gingival inflammation, can increase the chance of systemic dissemination of 
periodontopathogens and increase the risk of extra-oral infections and inflammation such as APO. 
Pregnancy exacerbates periodontal disease and suppresses immune responses, exposing the 
fetoplacental unit vulnerable to infection. Infection-initiated inflammation may induce preterm labor or 
preterm premature rupture of membrane, intrauterine growth restriction, low birth weight, or stillbirth. While 
our understanding of APO induced by the transmitted oral bacteria such as F. nucleatum has made 
tremendous progress in the past two decades, continuous efforts are warranted to investigate the 




Figure 1.1 Transmission electronic microscopy analysis of murine placentas infected with F. 
nucleatum 12230. (A) 24 hr post infection. R, red blood cells in the blood vessel. The solid arrows point to 
bacteria internalized in the endothelial cells lining the veins. The clear arrow points to an organism attached 
to the endothelial cells. Magnification, 6,000×. (B) 72 hr post infection. Arrows indicate bacteria that have 
proliferated in the cytoplasm or outside the cells. Magnification, 1,500×. (C) Enlarged view of the area boxed 






Figure 1.2 Scheme oaf hematogenous dissemination of oral Fusobacterium nucleatum to the 
placenta of pregnant women. F. nucleatum from the periodontal-diseased pocket of pregnant women 
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 Intrauterine infection is a leading cause of adverse pregnancy outcomes (APOs) including preterm 
birth, stillbirth, neonatal sepsis, preeclampsia, and even maternal mortality. Fusobacterium nucleatum is 
among the most prevalent microorganisms in intrauterine infection, implicated in 10-30% preterm births 
with its detection inversely related to the gestational age at birth (Fardini et al. 2010; Han et al. 2010; Miller 
et al. 1980; Chaim and Mazor 1992; Bearfield et al. 2002; Cahill et al. 2005; Ebersole et al. 2009). Bacteria 
detected in intrauterine infection has been conventionally suggested to ascend from the lower genital tract; 
however, F. nucleatum presents a surprising alternative in that it is absent in the normal vaginal flora, but 
instead is ubiquitous in the oral cavity frequently associated with periodontal disease (Hill 1998; 
Offenbacher et al. 1996). With pregnancy-associated gingivitis affecting 30-100% of the pregnant 
population, transient dental bacteremia is a frequent event during gestation (Onigbinde et al. 2014; Lieff et 
al. 2004; Carrillo-de-Albornoz et al. 2012; Ifesanya et al. 2010). It is now widely accepted that oral bacteria 
associated with periodontal disease can translocate through the bloodstream to the placenta to cause 
adverse pregnancy outcomes (Papapanou 2015; Katz et al. 2009; Han et al. 2010; Gauthier et al. 2011).  
 Our lab has previously established a mouse model of F. nucleatum-induced preterm and term 
stillbirth to study the mechanism of placental translocation, inflammation and parturition (Han et al. 2004). 
In this model, when F. nucleatum is injected into the tail vain of pregnant mice to mimic dental bacteremia, 
it colonizes specifically in the murine placenta. The bacteria are first detected in the venous sinuses or at 
foci adjacent to the venous sinuses in the decidua, followed by spreading beyond the decidua to the 
placental membranes and fetal vessels. The bacteria eventually spread to the amniotic fluids and fetuses 
after 2-3 days, resulting in fetal demise. Although F. nucleatum is detected in the liver and spleen of the 
dam at 6 hours following tail-vein injection, it is cleared after 24 hours. Thus, F. nucleatum infection is 
localized within the feto-placental unit, without causing systemic infection. This acute infection model is 
consistent with a previously reported human case of stillbirth, in which F. nucleatum was isolated from the 
mother’s subgingival plaque, placenta and the stillborn infant’s lung and stomach (Han et al. 2010).  
 Toll-like Receptors (TLRs) are pattern recognition receptors (PRRs) that recognize pathogen-
associated molecular patterns (PAMPs) to serve an immune surveillance role in the host innate immune 
response (Takeda and Akira 2015). TLR4 specifically recognizes lipopolysaccharide (LPS), an endotoxin 
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present on the outer membrane of Gram-negative bacteria. TLR2 recognizes a wide array of PAMPs 
including lipoproteins via heterodimerization with other TLRs. The binding of the specific ligands to the 
TLRs activates the transcription of pro-inflammatory molecules through two different pathways. The MyD88-
dependent pathway is regulated by Myeloid Differentiation Primary Response Gene 88 (MyD88) and TIR 
domain-Containing Adaptor Protein (TIRAP). Upon LPS binding to TLR4, MyD88 and TIRAP activate the 
nuclear translocation of transcription factors, nuclear factor kappa-light-chain-enhancer of activated B cells 
(NF-kB) and activator protein 1 (AP-1). Subsequently, NF-kB or AP-1 activation modulates the transcription 
of various pro- and anti-inflammatory genes to promote immune response. The second pathway, termed 
the MyD88-independent or TRIF-dependent pathway, involves the adaptor protein TIR-domain-containing 
adaptor inducing interferon-beta (TRIF). TRIF activates the NF-kB pathway and the subsequent 
inflammatory signals, as well as Interferon Regulatory Factor-3 (IRF3) for the production of Type 1 
interferons (IFNs).  
 The role of TLR2 and TLR4 in mediation of adverse pregnancy outcomes was investigated in the 
F. nucleatum infection model by testing mice genetically lacking TLR4 or TLR2 alongside wild type mice 
(Liu et al. 2007). In TLR4-deficient mice, the fetal death rate was reduced compared to wild type and TLR2-
deficient mice despite placental colonization with F. nucleatum. Histologic analysis of the placenta revealed 
no decidual necrosis or neutrophil infiltration in the TLR4-deficient mice in contrast to the wild type and 
TLR2-deficient mice. These results indicated that TLR4-activated inflammation was the cause of fetal 
demise. However, the source and the nature of inflammation was unknown. In this chapter, I examined the 
origin and the molecular mechanism of F. nucleatum-induced placental inflammation. 
 
 
Materials and Methods 
Bacterial strains and maintenance 
Fusobacterium nucleatum 12230 was maintained at 37ºC in anaerobic condition (90% N2, 5% CO2, 
5% H2), in Columbia broth (Becton Dickinson, Franklin Lakes, NJ) or Tryptic Soy Agar (TSA, Becton 
Dickinson, Franklin Lakes, NJ)  blood plate supplemented with 5 ug/mL hemin and 1 ug/mL menadione 
(Han et al. 2006). Staphylococcus aureus LAC USA300 CA-MRSA was obtained from Alice Prince 
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(Columbia University, New York, NY) and grown in Lysogeny Broth (Becton Dickinson, Franklin Lakes, NJ) 
or TSA blood plate.  
 
Mouse strains and husbandry 
C57BL/6 wild type and Trif-/- mice were purchased from the Jackson Laboratory (Bar Harbor, ME) 
and bred in-house. Tie2-Cre (Koni et al. 2001) and Vav1-iCre (de Boer et al. 2003) mice were gifts of Dr. 
Lei Ding (Columbia University, New York, NY). Tlr4-/- mice (Poltorak et al. 1998) were gifts of Dr. Robert 
Schwabe (Columbia University, New York, NY). Tlr4flox/flox mice (Sodhi et al. 2012) were obtained from 
Dr. David Hackam (Johns Hopkins University, Baltimore, MD). All mice were kept in sterilized filtered-
topped cages with 12-hour light cycle, fed autoclaved food (Pico Lab Mouse Diet 20 No. 5058; 22 kcal% 
fat, 55 kcal% carbohydrate, and 23 kcal% protein) and water ad libitum, and handled in a laminar flow hood. 
The animal protocol was approved by the Columbia University Institutional Animal Care and Use Committee 
(New York, NY).  
 
Mating and i.v. injection of mice 
Mating was conducted as previously described (Han et al. 2004). Briefly, mice were caged together 
at a female-to-male ratio of 2:1. Mating was determined by the presence of a white vaginal plug. The day 
when the plug was detected was termed day 1 of gestation. Mice were randomly distributed to study groups.  
Pregnant mice were injected with approximately 107 CFU of F. nucleatum on day 16 or 17 as 
described previously (Han et al. 2004). Briefly, F. nucleatum 12230 cultures were grown to exponential 
growth phase and prepared in sterile PBS suspension at an aimed concentration of 108 CFU/mL. The actual 
dose was determined by spotting serial dilutions of the prepared suspension on blood agar plates. A 
maximum volume of 100uL was injected into the tail vein. Injected mice were followed for birth outcomes 
or sacrificed at indicated time post-injection for placental analysis. The death rates of the fetuses and the 




Histological analysis of the placentas 
Mouse placentas were fixed in 4% paraformaldehyde, dehydrated in ethanol and embedded in paraffin. 
Cross-sections in 3 um thickness were placed on electro-charged slides and heated in a 600C oven for 1 
hour, deparaffinized in xylene, and rehydrated sequentially in 100, 95, and 75% ethanol and water. 
Antigen retrieval was performed in citrate-based low pH solution (Dako Omnis) for 30 minutes at 980C. 
After washing in tap water, endogenous peroxidase was quenched in 3% hydrogen peroxide, followed by 
cell permeabilization in 0.3% Triton X-100. Slides were incubated with 10% horse serum and 0.05% 
Tween 20 for 30 min, followed by rabbit anti-IL1β antibody (ab9722, Abcam), rabbit anti-NF-kB p65 
subunit antibody (CST8242, Cell Signaling Technology) or rabbit IgG isotype control for 2 hours at room 
temperature. After washes, slides were incubated with ImmPRESS HRP anti-rabbit IgG (Vector Lab) for 
30 min at room temperature.  Slides were developed with DAB Peroxidase Substrate Kit (Vector Lab) and 
counterstained with 20% hematoxylin followed by 1% ammonium hydroxide.  
 
Enzyme-linked immunosorbent assay (ELISA) 
Placental tissues (50mg) were homogenized in 500 µl tissue extraction reagent I (InvitrogenTM 
#FNN0071) with 5 µl protease inhibitor (Thermo) and 1% triton (Invitrogen). Total protein concentrations 
in the supernatants were measured using the BCA kit. IL1β was measured by ELISA Antibody Pair (REF 
CMC0813, Invitrogen) according to the manufacture’s protocol. 
 
Real-time quantitative PCR 
RNA was extracted from mouse placental tissues using a Qiagen RNeasy Mini Kit (Qiagen #74106). The 
quantity and quality of extracted RNA were measured using a NanoDrop ND 1000 spectrophotometer 
(NanoDrop Technologies). Complementary DNA (cDNA) was synthesized by reverse transcription PCR 
using the Superscript IV First-Strand Synthesis System (Invitrogen, #18091050) according to the 
manufacturer’s instructions. Real-time quantitative PCR was performed in duplicates, using 
StepOnePlusTM (Applied Biosystems). Each reaction was prepared with Power SYBR® Green PCR 
Master Mix kit according to the manufacturer’s instructions (Applied Biosystems). Specific forward and 
reverse primers, listed in the table below, were used at concentration of 500nM. PCR amplifications were 
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performed with 40 cycles of 95°C for 30 seconds, 59°C for 30 seconds, and 72°C for 30 seconds. The 
results were expressed as 2-ΔCt, where ΔCt is the difference between the mean Ct value of the targeted 
gene and the endogenous glyceraldehyde-3-phosphate dehydrogenase (GAPDH) or β-actin control. The 
fold change was calculated in comparison to the saline, PBS, or vehicle treated control groups. 
 
Western Blot 
Mouse placentas were pooled, homogenized, then lysed in Cell Lysis Buffer (Promega, Madison, WI) and 
centrifuged at 13,000 x g for 10 min at 4C. The protein concentration was measured using the BCA 
Protein Assay Kit (Thermo Fisher Scientific, Waltham, MA) according to the manufacturer’s instructions. 
One hundred microgram of total proteins was separated by 4-12% Bis-Tris Gel (Bio-Rad, Hercules, CA) 
and transferred to PVDF membranes (Bio-Rad, Hercules, CA). The membrane was blocked with 5% skim 
milk in TBS with 0.1% Tween-20 (TBST) at room temperature for 2 hours followed by primary antibodies 
β-actin (ab6276, Abcam, 1:4,000 dilution), Caspase-1 (ab1872, Abcam, 1:200 dilution), ASC1 (ab70627, 
Abcam, 1:1000 dilution), or NLRP3 (ab214185, Abcam, 1:1000 dilution) in 0.5% skim milk in TBST at 4C 
overnight. After washing three times with TBST, the membrane was incubated with HRP-conjugated 
secondary antibody in TBST at room temperature for 1 hour. The immune reactive bands were detected 
with SuperSignal West Pico PLUS Chemiluminescent Substrate (Thermo Fisher Scientific, Waltham, MA). 
 
Depletion of Neutrophils 
Non-pregnant mice were injected intravenously with 200 µg of rat anti-mouse Ly6G monoclonal antibody 
(BE0075, BioXCell) or rat IgG2a Isotype Control (BE0089, BioXCell) in a volume of 100 µL PBS once and 
again 48 hours later. Mice were bled from the tail tip and 100uL of blood was collected in capillary tubes 
every day for confirming neutrophil depletion in the circulation by flow cytometry. If mice were being 
injected on the same day, bleeding was performed 3 hours before the antibody or F. nucleatum injections. 
To test functional depletion, mice were injected intravenously with approximately 108 CFU of F. nucleatum 
in 100uL of PBS, 24 or 48 hours after the initial neutrophil depletion. The viability of F. nucleatum in the 





Blood cells were collected by tail-bleeding in heparin-coated capillary tubes (Sarstedt, Numbrecht, 
Germany), and 100 µL was used for surface staining for flow cytometry analysis. Bone marrow cells were 
collected from the right femur and digested with 0.5 mg/mL of Liberase TM (Roche) and 30 U/mL Dnase I 
(Roche) for 30 minutes at 37C. Spleen cells were collected by mashing through a 70uM cell strainer. Red 
blood cells were lysed by RBC lysis buffer (Biolegend) for 15 minutes at room temperature. All 
procedures following were performed on ice. Fc block (#101302, Biolegend) was carried out for 10 
minutes. Surface staining of 1-5 x 106 cells/ml in 100uL volume were carried out in PBS with 3% FBS. 
Antibodies against CD43 (#553270, Clone S7, Becton Dickinson), CD115 (#135506, Clone AFS98, 
Biolegend), CD19 (#115523, Clone 6D5, Biolegend), CD11b (#101226, Clone M1/70, Biolegend), Ly6C 
(#128011, Clone HK1.4, Biolegend), CD11c (#117347, Clone N418, Biolegend), CD45.2 (#109835, Clone 
104, Biolegend), Ter119 (#116222, Biolegend), CD48b (#108922, Clone DX5, Biolegend),  CD19 
(#115520, Clone 6D5, Biolegend), IAIE (#107620, Clone M5/114.15.2, Biolegend), CD3e (#25-0031-82, 
eBiosciences), F480 (#50-4801-82, Clone 145-2C11, eBiosciences), Ly6G (#56-5931-82, Clone RB6-
8C5, eBiosciences), NK1.1 (11-5941-82, Clone PK136, eBiosciences), and CD14 (45-0141-80, 
eBiosciences) were used. FACSCanto flow cytometer with FACSDiva software was used to analyze cells. 




All results are expressed as the mean ± SEM. Nonparametric Kruskal Wallis test with Conover post-test 
was used for comparison of fetal and neonatal death rates (InfoStat version 2014, Cordoba University, 
Cordoba Argentina). One-way ANOVA with Bonferroni post-test or two-way ANOVA with simple effects 
analysis and Student-Newman-Keuls (SNK) post-test were used for group comparisons (GraphPad Prism 
5.00 for Windows, San Diego, CA). All tests were two-sided, and a P-value less than 0.05 was 






TLR4 mediates placental inflammation caused by F. nucleatum 
 To investigate the host immune responses to F. nucleatum infection and elucidate the role TLR4 
plays in eliciting them, we induced dental bacteremia by injecting approximately 107 CFU into the tail vein 
of pregnant wild type C57BL/6 and Tlr4-/- mice as in previously established model (Han et al. 2004). 
Following F. nucleatum injection, inflammatory activation was observed in the placenta (Figure 2.1). We 
found temporal activation of pro-inflammatory genes (Figure 2.1A). At 24 hours following injection, a marked 
increase of the mRNA levels of the pro-inflammatory cytokines interleukin 1α (IL1α), tumor necrosis factor 
α (Tnfα), and granulocyte-macrophage colony-stimulating factor (Gmcsf/Csf2); chemokines monocyte 
chemotactic protein 1 (Mcp1/Ccl2), and chemokine ligand 5 (Ccl5/Rantes); as well as cyclooxygenase-2 
(Cox2), an enzyme mediating prostaglandin production during bacterial infection, was observed in 
comparison to the saline controls. At 48 hours, substantial induction of interleukin-1β (IL1β) mRNA, along 
with continued induction of Mcp1 and Gmcsf, was detected, suggesting a time-dependent exacerbation of 
inflammation (Figure 2.1A).  
 Hematoxylin and eosin staining of the placenta showed tissue necrosis and neutrophil infiltration in 
the infected placenta at 48 hours post-injection, but not in the uninfected control (Figure 2.1C and 2.1D). 
The protein levels of IL1β in the infected placentas were also significantly increased, as shown by 
immunohistochemical (IHC) staining (Figure 2.1E & 2.1F).   
 In contrast, in Tlr4-/- pregnant mice, no induction of inflammatory cytokines and chemokines was 
detected even after 48 hours of injection of F. nucleatum (Figure 2.1A). Interleukin-12 (IL12), interleukin-18 
(IL18), interleukin-6 (IL6), keratinocyte chemoattractant (KC/CXCL1), leukemia inhibitory factor (LIF), and 
hypoxia-inducible factor 1-alpha (HIF1a) were tested but not markedly induced in either wild type or TLR4-
/- mice (Figure 2.1B). These results demonstrate that induction of TLR4-mediated inflammatory responses 
precedes fetal death, which occurs after 48-72 hours following F. nucleatum injection (Han et al. 2004). 
 
F. nucleatum-induced placental inflammation originates from the maternal endothelial cells. 
 A placenta consists of cells derived from both maternal (decidua and maternal blood vessels) and 
fetal (cytotrophoblasts, syncytiotrophoblasts and fetal blood vessels) origins (Frost and Moore 2010). To 
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investigate the role of maternal and fetal TLR4 signals in the inflammatory response leading to parturition, 
Tlr4+/- chimeric placentas were generated by mating wild type C57BL/6 (Tlr4+/+) and Tlr4-/- parents, 
followed by F. nucleatum infection. The fetal and neonatal death rates from Tlr4+/+ dams and Tlr4-/- sires 
were similar to those whose parents were both Tlr4+/+ (Figure 2.2A).  In contrast, the death rates were 
substantially lower from Tlr4-/- dams regardless of the paternal genotypes (Figure 2.2A). Consistent with 
the birth outcomes, the expression levels of inflammatory cytokines and chemokines were markedly 
induced in placentas from Tlr4+/+, but not Tlr4-/-, dams, regardless of the paternal genotypes (Figure 2.2B 
& 2.2C). These observations support that fetal and neonatal death results from placental inflammation of 
the maternal origin.  
Hematopoietic and endothelial cells express various pattern recognition receptors (PRRs) such as 
TLRs and are active responders to hematogenous infections. To identify the maternal cell type(s) that elicit 
the inflammatory responses to F. nucleatum, two Cre-LoxP mouse strains were constructed: Vav1-
iCre;Tlr4flox/flox, with Tlr4 deleted in 100% hematopoietic cells (de Boer et al. 2003), and 
Tie2Cre;Tlr4flox/flox, with Tlr4 deleted in 80% hematopoietic and 100% endothelial cells (Koni et al. 2001; 
Constien et al. 2001). In comparison to the control group of Tlr4flox/flox, which are equivalent to those of 
Tlr4+/+, fetal and neonatal death rates following F. nucleatum infection were significantly reduced in Tie2-
Cre;Tlr4flox/flox mice, whereas no difference was detected in Vav1-iCre;Tlr4flox/flox mice (Figure 2.2A). 
Furthermore, the mRNA levels of inflammatory cytokines and chemokines were significantly reduced in F. 
nucleatum-infected placentas of Tie2-Cre;Tlr4flox/flox dams but not in those of Vav1-iCre;Tlr4flox/flox dams 
(Figure 2.2B). These results suggest that TLR4 in the endothelial cells are critical for causing placental 
inflammation and fetal and neonatal demise. 
To confirm this finding, we performed immunohistochemical analysis to examine NF-kB activation 
in the decidua. As early as 30 min after injection, nuclei translocation of the immunoreactive p65 subunit of 
NF-kB (aka RelA) was detected in the decidual endothelial cells of the wild type, Tlr4flox/flox and Vav1-
iCre;Tlr4flox/flox placentas (Figure 2.3A, 2.3D, 2.3F). After 2 hours, p65 was no longer detected in the 
endothelial nuclei, but was instead in the nuclei of the surrounding cells (Figure 2.3G, 2.3I). No nuclear 
translocation of p65 was detected in the saline-injected, F. nucleatum-infected Tlr4-/- or Tie2-
Cre;Tlr4flox/flox mouse placentas (Figure 2.3B, 2.3C, 2.3E, 2.3H), demonstrating that the decidual 
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endothelial TLR4 plays a critical role in NF-kB activation. By 6 hours after injection, nuclear NF-kB was 
detected further out in the spongiotrophoblast layer, and by 16 hours no more nuclear NF-kB was detected. 
We therefore conclude that placental inflammation originates from the maternal endothelial cells and spread 
to nearby cells over time in this model of placental infection. Combining the results from Figures 2.1 and 
2.3, a spatiotemporal pattern of the placental inflammation has emerged: the sequential NF-kB activation 
in the decidua precedes production of inflammatory cytokines and chemokines. 
 
TLR4-TRIF mediates the fetal and neonatal death  
  The TLR4-TRIF pathway, or the MyD88-independent pathway, utilizes the adaptor protein TRIF to 
activate NF-kB responses as well as Type 1 IFN responses. We tested the role of TRIF in F. nucleatum 
infection of the feto-placental unit, and the results were similar to those of TLR4 (Figure 2.4). The fetal and 
neonatal death rates of Trif-/- dam and sire as well as those of Trif-/- dam and Trif+/+ sire were significantly 
less than those of wild type C57B/6 mice, whereas those of Trif+/+ dam and Trif-/- sire were not different 
from those of wild types. This result confirmed that the maternal TRIF mediates adverse pregnancy 
outcomes in F. nucleatum infection.  
 Production of IL1β involves maturation by means of pro-form cleavage by caspase-1. Caspase-1 
is an protease that is activated by a multiprotein complex called inflammasome (He et al. 2016). 
Inflammasomes, upon sensing PAMPs or damage-associated molecular patterns (DAMPs), assemble 
intracellularly, consisting of a sensor, an adaptor, and an effector. The most well-studied NLRP3 
inflammasome uses NLRP3, a member of the Nod-Like receptor (NLR) family, as the sensor; apoptosis-
associated-speck like protein (ASC) as the adaptor; and caspase-1, a cysteine protease, as the effector. 
As substantial IL1β production has been noted throughout our experiments, we hypothesized that 
inflammasome activation is involved in the inflammatory response against F. nucleatum. To test, first we 
measured the mRNA transcription levels of different members of the NLR family (Figure 2.5A). In the 
placentas of wild type mice infected with F. nucleatum for 72 hours, NLRP3 gene expression was 
significantly increased compared to saline injected controls. After 48 hours of infection there was a trend of 
increase although it was not statistically significant. In NLRP1a and NLRC4, the mRNA levels were not 
different in infected placentas compared to noninfected. Next, we tested whether the other members of the 
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inflammasome complex were expressed in the infected placentas. At the time points tested, no significant 
increase was detected in caspase-1, ASC or HMGB1 transcription levels (Figure 2.5A). By Western blot, 
no conclusion could be drawn regarding the protein levels of NLRP3, ASC, or pro-caspase-1 (Figure 2.5B). 
Finally, NLRP3-deficient mice were tested for fetal and neonatal birth outcomes (Figure 2.5C). NLRP3-
deficient pups were born alive but ended up dead within one day after birth, as opposed to wild type mice 
whose neonatal death rate did not exhibit a dramatic change in the first day of life. These results suggest 
that NLRP3 may be required to protect the neonates from F. nucleatum infection, but further investigation 
is warranted in order to draw any conclusion.   
 
Monoclonal antibody depletes neutrophils from the circulation  
We suggest a possible role of neutrophil-derived inflammation in the F. nucelatum-induced adverse 
pregnancy outcomes. Depletion of neutrophils using specific antibodies has been a useful tool in 
investigating the role of neutrophils in a variety of diseases (Carr et al. 2011; Pino-Tamayo et al. 2016; 
Rinaldi et al. 2014). A study showed that depletion of neutrophils using Ly6G antibody in L. monocytogenes 
infection increased the susceptibility of mice due to lack of L. monocytogenes clearance from the liver. 
Another study observed that in LPS-induced PTB, neutrophil depletion led to reduced uterine IL1b and 
TNFa expression but did not delay PTB. Thus, I started to develop a protocol for neutrophil depletion for 
future analysis of its efficacy on F. nucleatum-induced adverse pregnancy outcomes. 
To deplete neutrophils in non-pregnant mice, we injected Ly6G (1A8) monoclonal antibody 
(BE0075, BioXCell) or isotype IgG control every other day for four days. To test the efficiency of neutrophil 
depletion, we determined the immunophenotypes of cells in non-pregnant mouse blood, spleen and the 
bone marrow after the injection of the antibodies. The blood was collected every day, and the bone marrow 
and spleen were collected four days after the initial injection. Flow cytometry analysis (Figure 2.6A) showed 
that the Ly6G antibody successfully depleted circulating neutrophils (Figure 2.6B) and in bone marrow 
(Figure 2.6C) and spleen (Figure 2.6D) compared to the IgG control. To test the effect of neutrophil 
depletion on neutrophil function, bacterial clearance activity was assessed (Figure 2.6E). Approximately 
108 CFU of F. nucleatum in exponential phase was intravenously injected to mice 24 hours after the injection 
of Ly6G or IgG control antibodies. The viability of F. nucleatum in the blood enumerated on blood agar 
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plates demonstrated a moderate increase in neutrophil-depleted mice compared to that of IgG control mice. 
At this time, neutrophil depletion assay has not been conducted in pregnant mice yet. However, the 
immunophenotyping of the cells in the blood, bone marrow and spleen of non-pregnant mice demonstrate 






Here we investigated the placental inflammatory response and its impact on pregnancy outcome 
using F. nucleatum as stimuli. F. nucleatum-induced placental inflammatory response exhibited a 
spatiotemporal pattern. TLR4-dependent activation of NF-kB was first detected in the decidual endothelial 
cells, and then in the neighboring tissues, followed by continuous induction of proinflammatory cytokines 
and chemokines. Inhibition of placental inflammation in mice lacking TLR4 led to protection of the fetuses, 
suggesting that the TLR4-mediated inflammatory responses are the cause, either direct or indirect, of fetal 
and neonatal demise. These results contrast with numerous other studies demonstrating TLR4 playing a 
protective role against bacterial infection (Branger et al. 2004; Song et al. 2009; Talbot et al. 2009; 
Bohannon et al. 2016; Faure et al. 2004; Chassin et al. 2009). In fact, TLR4 expression exclusively on 
endothelial cells have been shown to be sufficient to clear systemic E. coli infection in non-pregnant mice 
(Andonegui et al. 2009). The unusual deleterious role of TLR4 in placental infection possibly reflects the 
unique immunological features at the maternal-fetal interface. It appears that placental TLR4, especially 
the maternal endothelial TLR4, render the feto-placental unit highly sensitive to inflammatory responses to 
infectious microorganisms, causing harm rather than protection.  
Elimination of maternal but not paternal TLR4 inhibited placental inflammation. To the best of our 
knowledge, this is the first demonstration that intrauterine microbial infection triggers inflammation from the 
maternal lineage. Our study further identified the maternal endothelium as the origin of inflammation. This 
is consistent with our previous observation that F. nucleatum infection of the murine placenta is localized 
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primarily in the decidua (Han et al. 2004), where the maternal blood is perfused into the placenta and no 
fetal vasculature is present (Choudhury et al. 2017; Georgiades et al. 2002). The endothelial cells play an 
important role in early modulation of immune response against infectious microorganisms, marked by 
increased permeability, leukocyte adherence and angiogenesis (Al-Soudi et al. 2017). In our model of 
hematogenous infection, the endothelial cells are understandably the first to come into contact with the 
pathogen. Elimination of endothelial TLR4 blocked the downstream placental inflammation and protected 
the fetuses from F. nucleatum infection. This is consistent with our previous observation of sequential 
detection of F. nucleatum in the blood vessels and adherence and invasion of the endothelial cells, followed 
by colonization and proliferation in the decidua of infected placentas. 
 We report that in the absence of maternal TRIF, where MyD88 is still present, no adverse 
pregnancy outcomes in response to F. nucleatum infection were detected, suggesting a MyD88-indepdent 
TLR4-TRIF pathway activation. Given that both TRIF- and MyD88-dependent pathways activate NF-kB 
downstream, and that we observe NF-kB activation in the early phase of placental inflammation, it is 
important to delineate whether MyD88-NF-kB activation is dispensable. A limitation of our study is that we 
were not able to test our model in MyD88-deficient mice. A significant mortality and morbidity in breeding 
colonies of this strain has been reported, attributable to the compromised mounting of immune response to 
common contaminants such as Pseudomonas spp. (Villano et al. 2014). However, the finding that the lack 
of TRIF signaling could not be compensated by MyD88-dependent pathway suggests that MyD88-
dependent signaling does not affect the birth outcome in F. nucleatum infection. One way to still test the 
role of MyD88 pathway in our model would be to use TIRAP-deficient mice. TIRAP, or Myd88-adaptor-like 
(Mal), is an adaptor protein necessary to recruit MyD88 in TLR4 or TLR2 activation, therefore can be 
hypothesized to transduce the TLR4 signaling during F. nucleatum infection one step upstream of MyD88.  
 As we report that TLR4-TRIF-NF-kB pathway regulates the placental inflammation, the next step 
would be to verify whether F. nucleatum-induced placental inflammation also requires the activation of 
TLR4-TRIF-IRF3 pathway, involving Type 1 IFN responses (Boxx and Cheng 2016). Type 1 IFNs are 
typically associated with antiviral host response and adaptive immunity, but their roles in antibacterial and 
innate response have also been described. In addition, TLR4-TRIF-IRF3-IFN has been shown to mediate 
the activation of NLRP3 inflammasome (Rathinam et al. 2012). The study of Rathinam et al. conducted in 
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mouse bone marrow derived macrophages (BMDM) stimulated with Gram-negative bacteria demonstrated 
that TLR4, TRIF and IFN-Alpha/Beta Receptor (IFNAR), but not MyD88, were required for Caspase-11 and 
eventually caspase-1 activation and IL1b maturation. As we detect high levels of IL1b mRNA and protein 
expression in the infected placentas as well as propose a possible role of NLRP3 inflammasome in the fetal 
death induced by F. nucleatum infection, defining the pathway by which IL1b is cleaved will significantly 
enhance the understanding of the inflammatory mechanisms. The possible activation of TLR4-TRIF-IRF3 
pathway during the placental inflammation presents a hypothesis to explain the IL1b maturation for future 
investigations. 
 NLRP3 was tested for its role in fetal and neonatal death induced by F. nucleatum infection. 
Interestingly, Nlrp3-/- pups exposed to F. nucleatum in utero were born alive at term but died shortly after, 
as opposed to the wild type pups that were born dead preterm. This suggests that while NLRP3 orchestrates 
the events leading up to fetal death, it may play a role in protecting the neonates after birth. However, 
whether NLRP3 functions as a part of the inflammasome complex, in the placental inflammation including 
IL1b maturation in utero, and its role in neonates after birth, needs further investigation. NLRP3 transcription 
levels were not significantly increased at 48 hours after infection but were only significant at 72 hours after 
infection. Given the transcriptional activation in the later part of the observed inflammation, NLRP3 may be 
a part of preterm onset of parturition itself rather than the early inflammatory response (Gomez-Lopez et al. 
2018; Panaitescu et al. 2019).  
An alternative hypothesis exists for IL1β cleavage. Inflammasome-independent IL1β release has 
been reported to occur in certain localized inflammations (Netea et al. 2010). Fantuzzi et al. reported a 
scenario of IL1β-mediated inflammation completely independent of inflammasome by demonstrating IL1β 
maturation in caspase-1 deficient mice (Fantuzzi et al. 1997). Several enzymes other than caspase-1 have 
been reported to cleave inactive IL1 family cytokines, including neutrophil-derived serine proteases such 
as proteinase 3, neutrophil elastase, and cathepsin-G as well as matrix metalloproteinases (Coeshott et al. 
1999; Schönbeck et al. 1998; Joosten et al. 2009). Such proteases are thought to be released into the 
extracellular matrix by activated neutrophils which in turn process the inactive IL1b and other IL1 cytokines 
released from necrotic cells (Clancy et al. 2018). Evidence of neutrophil-dependent, inflammasome-
independent processing of IL1β has been reported in human diseases such as ulcerative colitis, Chagas 
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cardiomyopathy,  and acute arthritis (Ranson et al. 2018; Medeiros et al. 2019; Guma et al. 2009). All three 
diseases are characterized by neutrophil-mediated inflammation. In fact, our model of acute F. nucleatum 
placental infection involves a remarkable infiltration of neutrophils, and it is possible that the IL1β activation 
is mediated by neutrophil-derived proteases instead of inflammasome. Using the scheme developed in this 
study, the effect of neutrophils on F. nucleatum-induced placental infection can be assessed in the furture 
Survival of fetuses, placental inflammation and placental colonization by F. nucleatum in the absence of 
neutrophils will all be of interest for investigation. 
A preliminary transcriptomic analysis of the F. nculeatum-infected placentas has been conducted 
to gain a comprehensive understanding of the host response (Appendix I). However, the quality of the RNA 
sample became questionable due to a considerable amount of DNA detected across the samples. 
Therefore, the data was included as an Appendix rather than the main body of the thesis and are only to 
























































































































Figure 2.1. F. nucleatum induces placental inflammation through TLR4. On day 16 or 17 of gestation, 
each C57BL/6 wild type or TLR4-/- mouse received approximately 107 CFU of F. nucleatum 12230 or saline. 
(A and B) At 24 or 48 hours after injection, the placentas were collected for RNA extraction. The mRNA 
levels of inflammatory cytokines and chemokines were measured by real-time quantitative PCR and are 
expressed in fold change compared to the saline-injected control group. At least 4 pregnant mice were 
included in each group. The results are presented as dot plots with average and SEM. Two-way analyses 
of variance (ANOVA) was performed with simple effects analysis when the interaction was significant. Post-
hoc test using Student-Newman-Keuls (SNK) was applied for post-hoc comparisons. *p<0.05, **p<0.01. 
(C-F) H&E staining (C and D) and immunohistochemical staining of IL-1b (E and F) in the decidua of wild 
type mice at 48 hours after injection with saline (C and E) or approximately 107 CFU of F. nucleatum (D 
and F). Original magnifications, 100x (C and D); 500x (E and F); 3x zoom from 100x (D inset). 
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Figure 2.2. F. nucleatum–induced placental inflammation originates from the maternal endothelial 
cells. Approximately 107 CFU F. nucleatum 12230 or saline was injected into the tail vein of each C57BL/6 
pregnant dam on day 16 or 17 of gestation. (A) The fetal and neonatal death rate was calculated as the 
percentage of dead fetuses and neonates per litter at birth and followed up to 3 days after birth. Genotypes 
of the mating parents are shown below the x axis. Each geometric symbol represents 1 pregnant mouse. 
At least 8 pregnant mice were tested per group. The horizontal lines indicate the average death rates. (B) 
mRNA levels in the placentas measured by real-time quantitative PCR and expressed as fold changes 
compared with each genotypes’ own saline-injected control groups. At least 3 pregnant dams were included 
in each group. (C) Protein levels of IL-1β in the placentas, as determined by ELISA. At least 3 pregnant 
dams were included in each group. For B and C, the placentas were collected at 48 hours after injection 
and pooled for each pregnant dam. The results are presented as dot plots with average and SEM. Two-
way ANOVA was performed with simple-effects analysis when the interaction was significant. Post-hoc test 
using Student-Newman-Keuls was applied for post-hoc comparisons. *P < 0.05, **P < 0.01, ***P < 0.001. 





 Figure 2.3. F. nucleatum induces nuclear translocation of the p65 subunit of NF-κB in the decidua. 
Immunohistochemical staining of the p65 subunit of NF-κB in the decidua of wild type C57BL/6 (A, B, and 
G), Tlr4-/- (C), Tlr4f/f(D), Tie2-Cre;Tlr4f/f(E and H), and Vav1-iCre;Tlr4f/f(F and I) mice at 30 minutes (A–
F) and 2 hours (G–I) after injection with saline (B) or approximately 107 CFU F. nucleatum (A, C, and D–
I). Immunoreactive p65 was detected in the endothelial nuclei in A, D, and F and in the cells surrounding 
the venous sinuses (V) in G and I (insets). No nuclear p65 was detected in B, C, E, or H. Original 
magnification, 500x; 4x zoom  from 500x (A, D, F, G, and I insets). Representative image from 4 placentas 
from 2 dams of each group was selected.  
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Figure 2.4. Maternal TRIF mediates F. nucleatum–induced fetal and neonatal death. Approximately 
10
7
 CFU F. nucleatum 12230 or saline was injected into the tail vein of Trif-/-  pregnant dam on day 16 or 
17 of gestation. The fetal and neonatal death rate was calculated as the percentage of dead fetuses and 
neonates per litter at birth and followed up to 3 days after birth. Genotypes of the mating parents are shown 
below the x axis. Each geometric symbol represents 1 pregnant mouse; at least 8 were tested in each 
group. The horizontal lines indicate the average death rates. The results are presented as dot plots with 
average and SEM. Two-way ANOVA was performed with simple-effects analysis when the interaction was 
significant. Post-hoc test using Student-Newman-Keuls was applied for post-hoc comparisons. *P < 0.05, 
**P < 0.01.   
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Figure 2.5. NLRP3 inflammasome does not mediate F. nucleatum-induced neonatal death. On day 
16 or 17 of gestation, each Nlrp3-/- mouse received approximately 107 CFU of F. nucleatum 12230 or saline. 
(A) At 48 or 72 hours after injection, the placentas were collected for RNA extraction. The mRNA levels of 
inflammasome-related genes were measured by real-time quantitative PCR and are expressed in fold 
change compared to the saline-injected control group. The results are presented as dot plots with average 
and SEM. One-way ANOVA with Bonferroni post-test was performed. N=3 each. *p<0.05, **p<0.01. (B) At 
6, 24, 48 and 72 hours after injection, placentas were collected for immunoblotting against NLRP3, pro-
caspase 1 and ASC, with beta-actin as internal control. (C) The neonatal death rate of wild type and Nlrp3-
/- mice were calculated as the percentage of dead neonates per litter at birth and 1 days after birth. Each 
geometric symbol represents 1 pregnant mouse, and the same-colored symbols represent the same dam. 
The horizontal lines indicate the average death rates. The results are presented as dot plots with average 
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Figure 2.6. Neutrophil depletion by specific antibody in non-pregnant mouse moderately increases 
F. nucleatum viability in the circulation. Non-pregnant mice were injected intravenously with Ly6G (1A8) 
antibody and isotype IgG control on Day 0 and Day 2. Mice were bled every day from Day 0 to Day 4, 
before injection of Ab on Day 0 and Day 2. Bone marrow and spleen were collected on Day 4. n=2 in each 
group (A-D) Representative flow cytometry analysis. (A) Gating strategy of flow cytometry analysis for 
neutrophils. Live immune cells were gated by DAPI-/CD45+ (1), single cells were gated by aggregate 
exclusion (2), myeloid cells were gated by CD11b+ (3), and neutrophils were gated by Gr1+ (4). 
Representative neutrophil gating in Ly6G Ab and isotype IgG control injected mouse blood (B), bone 
marrow (C), and spleen (D). (E) Approximately 108 CFU of F. nucleatum was injected to neutrophil-depleted 
mice on Day 1 and followed 3, 6, 9 and 24 hours for viability. Live F. nucleatum in the blood were counted 
by enumeration on blood agar plate. Values are expressed as Log(CFU per mL of blood) with mean ± SEM.  
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Preterm birth (PTB) is a global burden with over 10% prevalence of all births and accounting for 
over 35% infant mortality in the U.S. (Martin et al., 2018; Matthews et al., 2015). Intrauterine infection is 
attributed for 25-40% of PTB and may lead to serious maternal and neonatal morbidity (Andrews et al., 
1995; Goldenberg et al., 2008; Rouse et al., 2004). Oral bacteria, Fusobacterium nucleatum in particular, 
have been proposed as an etiologic agent in intrauterine infection and the consequent adverse pregnancy 
outcomes (Han, 2011; Vander Haar et al., 2018). Pregnancy renders a woman highly susceptible to 
periodontal disease, leading to an enriched reservoir of potential infectious microbes in the oral cavity 
(Basavaraju et al., 2012; Cobb et al., 2017). Current management of chorioamnionitis or Triple I, 
“Inflammation or infection or both” in the chorion and/or amnion, largely depends on antibiotics upon 
diagnosis in both intra- and postpartum women and the newborn (Committee on Obstetric Practice, 2017; 
Higgins et al., 2016). However, considering that in many cases intrauterine infection goes through a 
subclinical stage, by the time of diagnosis the inflammation may have already manifested through 
pregnancy, too late for antibiotic treatments (Gomez et al., 2007; Yoon et al., 2001). On the other hand, 
prophylactic administration of antibiotics in high risk women is not beneficial and may even be harmful 
(Flenady et al., 2013; Thinkhamrop et al., 2015).  
Dietary supplementation of omega-3 polyunsaturated fatty acids (PUFAs) has been widely used to 
reduce inflammation in chronic inflammatory diseases such as cardiovascular disease and rheumatoid 
arthritis, and has been safely recommended for use during pregnancy (Calder, 2017; Dunstan et al., 2008; 
Gioxari et al., 2018; Greenberg et al., 2008; Helland et al., 2003; Olsen et al., 1992; Veselinovic et al., 2017; 
Yates et al., 2014). Humans consuming a diet rich in omega-3 oil have been shown to harbor increased 
quantities of omega-3 fatty acids such as eicosapentaenoic acid (20:5n-3; EPA) and docosahexaenoic acid 
(22:6n-3; DHA) in their cellular phospholipid membranes (Yaqoob et al., 2000) and in breast milk (Helland 
et al., 1998). Increase in omega-3 fatty acids in the cellular composition has been associated with anti-
inflammatory and immunosuppressive properties, although the extent and the mechanism of immune 
modulation may vary depending on the nature of fatty acids, source of infection and inflammation, and 
infected tissue or cell types (Gioxari et al., 2018; Guo et al., 2017; Kar et al., 2016; Saccone and Berghella, 
2015; Søyland et al., 1993, 1994; Watanabe and Tatsuno, 2017).  
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Use of omega-3 fatty acids to reduce the risk of preterm birth has been tested but the results are 
inconclusive. Makrides et al. and Carlson et al. reported fewer incidents of early PTB in omega-3 
supplemented group compared to controls, consistent with the conclusion from a recently updated 
Cochrane review (Carlson et al., 2013; Makrides et al., 2010; Middleton et al., 2018). Some other trials have 
reported no beneficial effect of omega-3 supplementation on the length of gestation (Kar et al., 2016; 
Saccone and Berghella, 2015). However, no study has been conducted on the effect of omega-3 
supplementation on prevention of intrauterine infection-related adverse pregnancy outcomes, despite the 
evidence of its beneficial effects in infectious disease (Al-Biltagi et al., 2017; Chen et al., 2018; Svahn et 
al., 2016). Here, we examine the effect of omega-3 fatty acids supplementation in F. nucleatum-induced 
placental inflammation and the birth outcomes of pregnant mice, and its potential broad implication in 
infections by other pathogenic microbes.  
 
 
Materials and Methods 
Bacterial strains and maintenance 
Fusobacterium nucleatum 12230 was maintained at 37ºC under anaerobic condition (90% N2, 5% 
CO2, 5% H2), in Columbia broth (Becton Dickinson, Franklin Lakes, NJ) or Tryptic Soy Agar (TSA, Becton 
Dickinson, Franklin Lakes, NJ) blood plate (5% sheep blood, Thermo Scientific) supplemented with 5 ug/mL 
hemin and 1 ug/mL menaidione (Han et al., 2006). Community-associated methicillin-resistant 
Staphylococcus aureus (CA-MRSA) LAC-USA300 was obtained from Alice Prince (Columbia University, 
New York, New York, USA) and grown in Luria-Bertani (LB, Becton Dickinson, Franklin Lakes, NJ) medium 
or on TSA (Becton Dickinson, Franklin Lakes, NJ) plates. Listeria monocytogenes 10403S was obtained 
from Mimi Shirazu-Hiza (Columbia University, New York, NY) and grown in Brain Heart Infusion (BHI, 
Becton Dickinson, Franklin Lakes, NJ) medium or on LB agar plate.  
 
Mouse strains and husbandry 
69 
 
CF-1 wild type mice were purchased from National Cancer Institute Mouse Repository or Charles 
River Laboratories (Wilmington, MA). C57BL/6 mice were purchased from the Jackson Laboratory (Bar 
Harbor, ME) and bred in-house. All mice were kept in sterilized filtered-topped cages with 12-hour light 
cycle, fed autoclaved food (PicoLab Mouse Diet 20 No. 5058; 22 kcal% fat, 55 kcal% carbohydrate, and 23 
kcal% protein) and water ad libitum, and handled in a laminar flow hood. The animal protocol was approved 
by the Columbia University Institutional Animal Care and Use Committee (New York, NY).  
 
Mating, fish oil administration, and i.v. injection of mice 
Mating was conducted as previously described (Han et al., 2004). Briefly, mice were caged together 
at a female-to-male ratio of 2:1. Mating was determined by the presence of a white vaginal plug. The day 
when the plug was detected was termed day 1 of gestation. Mice were randomly distributed to study groups.  
Omega-3 oil group received 3, 16 or 33 mg of omega-3 fatty acids in 10, 50, 100 uL of commercial 
fish oil every other day (for C57BL/6) or every day (for CF-1) from day 1 to day 16 of gestation by oral 
gavage. Gavage schedule was determined through consultation with the vet to minimize the distress and 
perturbation of mouse physiology. Control group received equal volume of sterilized water (C57BL/6) or 
nothing (CF-1).   
Pregnant mice were injected with approximately 107 CFU of F. nucleatum on day 16 or 17 as 
described previously (Han et al., 2004). Briefly, F. nucleatum 12230 cultures were grown to exponential 
growth phase and resuspended in sterile PBS suspension at an aimed concentration of 108 CFU/mL. The 
actual dose was determined by spotting serial dilutions of the prepared suspension on blood agar plates. 
A maximum volume of 100uL was injected into the tail vein. Injected mice were followed for birth outcomes 
or sacrificed at indicated times post-injection for placental analysis. The death rates of the fetuses and the 
neonates were recorded up to three days after birth. 
 
Enumeration of viable F. nucleatum in the placentas 
Mice were sacrificed at indicated time post-injection, and placentas of each dam were pooled and 
processed for further analyses. The live bacterial titer in the placentas was determined by suspending 
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pooled and mashed placentas in sterile PBS and spotting serial dilutions on blood agar plates. The titer 
was expressed as log CFU/gram tissue.  
 
Endothelial cell culture and omega-3 fatty acids supplementation 
Primary cultures of human umbilical vein endothelial cells (HUVECs) were obtained from Jan 
Kitajewski lab, where they were isolated as previously described (Jaffe et al., 1973). The cells were 
maintained at 37°C in 5% CO2 in complete medium using EGM-2 Bullet Kit (LONZA, NJ). HUVECs were 
seeded into 6-well plates coated with rat collagen type I (Corning #354236) and allowed to grow to 
confluency. For fatty acids treatment, DHA, EPA, AA, or equal volume of absolute ethanol as vehicle control 
were mixed with 1% low-fatty-acid and endotoxin-free bovine serum albumin (BSA, US Biological, #A1311). 
Growth medium was replaced with antibiotics-free medium containing indicated concentrations of the fatty 
acids or vehicle control for 3 hours, followed by incubation with F. nucleatum 12230, ultra-pure 
lipopolysaccharide (LPS) from Escherichia coli 0111:B4 (Invivogen, tlrl-3pelps), or N-palmitoyl(S)-[2,3-
bis(palmitoyloxy)-(2, RS)-propyl]-Cys-Ser-Lys4 (Pam3CSK4) (Invivogen, tlrl-pms) for 24 hours, S. aureus 
for 5 hours, or L. monocytogenes for 4.5 hours. 
 
Real-time quantitative PCR 
RNA was extracted from HUVECs or mouse placental tissues using Qiagen RNeasy Mini Kit 
(Qiagen #74106). The quantity and quality of extracted RNA were measured using a NanoDrop ND 1000 
spectrophotometer (NanoDrop Technologies). Complementary DNA (cDNA) was synthesized by reverse 
transcription PCR using the Superscript IV First-Strand Synthesis System (Invitrogen, #18091050) 
according to the manufacturer’s instructions. Real-time quantitative PCR was performed in duplicates, 
using StepOnePlusTM (Applied Biosystems). Each reaction was prepared with Power SYBR® Green PCR 
Master Mix kit according to the manufacturer’s instructions (Applied Biosystems). Specific forward and 
reverse primers, listed in the table below, were used at concentration of 500nM. PCR amplifications were 
performed with 40 cycles of 95°C for 30 seconds, 59°C for 30 seconds, and 72°C for 30 seconds. The 
results were expressed as 2-ΔCt, where ΔCt is the difference between the mean Ct value of the targeted 
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gene and the endogenous glyceraldehyde-3-phosphate dehydrogenase (GAPDH) or β-actin control. The 
fold change was calculated in comparison to the saline, PBS, or vehicle treated control groups. 
 
Flow cytometry 
Cells were harvested from the mouse placenta or the peritoneum. Placentas were pooled and 
homogenized in a blender bag, then passed through a 70uM cell strainer. Enzymatic digestion was 
performed with 0.5 mg/mL of Liberase TM (Roche) and 30 U/mL DNase I (Roche) for 30 minutes at 37C. 
Red blood cells were lysed by RBC lysis buffer (Biolegend) for 15 minutes at room temperature. Peritoneal 
cells were collected by injecting 5 mL of ice cold PBS with 3% fetal bovine serum (FBS) into the peritoneal 
cavity, gently massaging the peritoneum to dislodge attached cells, and aspirating as much fluid as 
possible. Surface staining was carried out on ice in PBS with 3% FBS after 10 minutes of Fc block 
(Biolegend, San Diego, CA). Antibodies against CD45 (#553081, Clone 30-F11, Becton Dickinson) and 
Ly6G (#560601, Clone 1A8, Becton Dickinson) were used. FACSCanto flow cytometer with FACSDiva 
software was used to analyze cells. Data was analyzed using Flowjo (Flowjo, LLC, Ashland, Oregon).  
 
Statistics 
All results are expressed as the mean ± SEM. Nonparametric Kruskal Wallis test with Conover 
post-test was used for comparison of fetal and neonatal death rates (InfoStat version 2014, Cordoba 
University, Cordoba Argentina). One-way ANOVA with Bonferroni post-test or two-way ANOVA with simple 
effects analysis and Student-Newman-Keuls (SNK) post-test were used for group comparisons (GraphPad 
Prism 5.00 for Windows, San Diego, CA). The logrank (Mantel-Cox) test was performed for survival curve 
comparison (GraphPad Prism 5.00 for Windows, San Diego, CA). All tests were two-sided, and a P-value 








To determine their anti-inflammatory effects in endothelial cells, purified omega-3 fatty acids, EPA 
and DHA, mixed at 3:1 ratio, were pre-incubated with primary cultures of human umbilical vein endothelial 
cells (HUVEC) prior to addition of F. nucleatum 12230 at multiplicity of infection (MOI) of 50:1 A common 
omega-6 fatty acid, arachidonic acid (20:4n-6; AA), was tested as a control. The mRNA expression levels 
of MCP1, interleukin 8 (IL8), CCL5, IL1β, interleukin 6 (IL6), and the endothelial activation markers 
intercellular adhesion molecule 1 (ICAM1) and E-selectin were induced by F. nucleatum, but the induction 
was substantially suppressed in cells pre-incubated with omega-3 fatty acids in a dose-dependent manner 
(Figure 3.1). In contrast, only a few inflammatory markers were inhibited by omega-6 fatty acids even at the 
maximum dose tested (Figure 3.1). 
 In order to test if the effect of omega-3 fatty acids is specific for F. nucleatum, HUVEC were infected 
with community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) LAC-USA 300, a 
Gram-positive pathogen and a leading cause of health care-associated infections (Tong et al., 2015). 
Omega-3 fatty acids more effectively reduced the expression of all inflammatory genes tested than omega-
6 fatty acids did (Figure 3.2A). To determine if omega-3 fatty acids alleviate the inflammatory responses 
mediated through TLR signaling, we tested expression of inflammatory cytokines and chemokines in 
primary HUVEC following incubation with purified E.coli lipopolysaccharide (LPS), a TLR4 agonist, and 
Pam3CSK, a TLR2 agonist (Figure 3.2B). While both LPS and Pam3CSK upregulated expression of the 
inflammatory genes, cells pre-incubated with omega-3 fatty acids exhibited markedly lower inflammatory 
responses to both LPS and Pam3CSK. Omega-6 fatty acids showed no inhibitory effect. These results 
demonstrate that omega-3 fatty acids effectively suppress endothelial inflammation induced by both Gram-
negative and Gram-positive microorganisms.  
 
Dietary omega-3 fatty acids suppress F. nucleatum-induced placental inflammation and protect 
fetuses 
For in vivo testing, pregnant mice were orally gavaged with commercial fish oil as a source of 
omega-3 fatty acids throughout the gestation until they were injected with F. nucleatum. Mice were gavaged 
with 3, 16, or 33mg of omega-3 fatty acids in 10, 50, or 100 uL fish oil, every other day (C57BL/6) or every 
day (CF-1). The supplementation did not affect the maternal body weight (Figure 3.3).  The fetal and 
73 
 
neonatal death rate was markedly reduced in C57BL/6 mice fed with 33 mg of omega-3 fatty acids 
compared to the water-gavaged controls (Figure 3.4A). In order to determine if the observed fetal and 
neonatal protection was specific to C57BL/6 mice, and because humans are outbred, the outbred CF-1 
mice were also tested. Similar results were obtained, and a dose-dependent pattern was observed. A trend 
of fetal and neonatal death reduction was detected at a lower dose of 3 mg omega-3 fatty acids, which 
reached significance at a higher dose of 16 mg (Figure 3.4C). Placental inflammation was suppressed by 
omega-3 fatty acids in both C57BL/6 and CF-1 mice as shown by real-time qPCR analysis of inflammatory 
molecules at 48 hours post F. nucleatum injection (Figure 3.4B & 3.4D).  
Surprisingly, omega-3 fatty acids also suppressed F. nucleatum proliferation in the placenta. In 
both C57BL/6 and CF-1 mice, the live bacterial titers increased with time in the control placentas, consistent 
with previous report (Han et al., 2004); however, they remained stagnant in C57BL/6 and decreased in CF-
1 placentas following supplementation with omega-3 oils (Figure 3.4E & 3.4F). Bacteriostatic properties of 
omega-3 fatty acids have been reported for Helicobacter pylori both in vitro and in vivo (Correia et al., 2012; 
Park et al., 2015; Thompson et al., 1994), suggesting omega-3 fatty acids as potential preventives for H. 
pylori-associated gastric diseases. However, for F. nucleatum, in vitro testing showed that omega-3 fatty 
acids exhibited no bacteriostatic or bactericidal effects (Figure 3.5).  It is likely that the lack of proliferation 
is secondary to the suppression of inflammation due to the possible inflammophilic nature of F. nucleatum 
(Hajishengallis, 2014). In support of this possibility is the observation that the immune suppression was 
detected at 48 hours, but the stagnation of proliferation in C57BL/6 was not evident until 72 hours post-
injection (Figure 3.4C & 3.4E). In addition, F. nucleatum titers in Tlr4-/- placentas exhibited stagnation after 
48 hours, with or without omega-3 oil supplementation, further supporting that the lack of inflammation 
prohibited sustained bacterial proliferation (Figure 3.6). 
   
Omega-3 fatty acids do not increase neutrophil infiltration to the site of F. nucleatum infection 
 Another hypothesis to explain the lack of F. nucleatum proliferation in the placentas from mice 
supplemented with omega-3 fatty acids is enhanced clearance of bacteria by the immune cells, specifically 
neutrophils. Failure of neutrophil migration to the infection site result in impaired bacterial clearance and is 
a hallmark of sepsis (Alves-Filho et al., 2010). Is it possible that during F. nucleatum-induced placental 
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infection, supplementation with omega-3 fatty acids allows a more effective neutrophil recruitment to the 
site of infection, thus improving bacterial clearance? To test this hypothesis, HUVECs pre-incubated with 
omega-3 fatty acids were infected with F. nucleatum for one hour. A significantly higher expression of IL8, 
a chemoattractant of neutrophils, was observed (Figure 3.7). No other chemokines or cytokines tested were 
expressed higher than the baseline at this time point. We then examined whether supplementation of 
omega-3 fatty acids in non-pregnant or pregnant mice had any effect on neutrophil infiltration in response 
to infection with F. nucleatum (Figure 3.8). Flow cytometry analyses were performed to assess the 
percentage of neutrophils among immune cells in the peritoneum or the placentas of infected mice (Figure 
3.8A). When F. nucleatum was injected into the peritoneum of mice orally gavaged with omega-3 fatty acids 
for two weeks (33mg, every other day), the percentage of neutrophils out of all immune cells recruited in 
the peritoneum showed an insignificant trend of increase compared to that of the control mice (Figure 3.8 
B and C). In pregnant mice with F. nucleatum injected into the tail vein, supplementation with omega-3 fatty 
acids (33mg, every other day, 2 weeks) resulted in no difference in the percentage of the neutrophils out of 
all immune cells in the infected placentas compared to the water-fed controls (Figure 3.8 D and E). The in 
vivo results shows that under the conditions tested, omega-3 fatty acids supplementation does not facilitate 
increased recruitment of neutrophils to the site of F. nucleatum infection, which contrasts from the in vitro 
results   
 
Dietary omega-3 fatty acids increase susceptibility of pregnant mouse to Listeria monocytogenes 
infection 
Listeria monocytogenes is a Gram-positive, intracellular pathogen and a source of foodborne illness 
with a high mortality rate of 20% in those affected (Allerberger, 2003). Although rare with only around 1,600 
cases estimated to occur per year in the U.S., 14-20% of all listeriosis are related to pregnancy and the 
mortality rate for fetal or neonatal listeriosis is over 50% ]. In a prospective study of 107 pregnant patients 
with listeriosis, all women recovered from the infection, but 95% had a complicated delivery; among those, 
24% experienced fetal loss, 45% PTB, and 21% acute fetal distress (Charlier et al., 2017). Listeria enters 
the system through the gastrointestinal barrier and spreads hematogenously and invade across the 
placental and blood-brain barrier (Hamon et al., 2006). Current treatment relies on administration of 
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antibiotics upon detection of maternal listeriosis, but this does not ensure protection of the fetus in a timely 
manner, as the incubation period of listeriosis can range from 1 to 67 days, with 8 days being the median 
(Goulet et al., 2013; Mateus et al., 2013). Prevention of maternal listeriosis is limited to following of general 
food safety protocol. In addition to the anti-inflammatory characteristics, omega-3 fatty acids have been 
tested for its antimicrobial properties against foodborne pathogens including L. monocytogenes, which was 
reported to be effective (Shin et al., 2007). Considering the detrimental outcomes of fetal and neonatal 
listeriosis including neonatal septicemia, meningitis, respiratory distress and even death, finding a 
prophylaxis care would be valuable.  
Pregnant C57BL/6 mice were gavaged omega-3 fatty acids (33mg/100uL) or water of equal volume 
every other day throughout the gestation, followed by intragastric inoculation with L. monocytogenes 
10403S at approximately 5x108 CFU on day 16 or 17.  Omega-3 fatty acids showed no effect on birth 
outcomes after Listeria infection compared to controls (Figure 3.9A). Surprisingly, dams fed with omega-3 
fatty acids prior to infection had higher mortality, albeit insignificant (p=0.11) (Figure 3.9B). Out of a total of 
14 omeag-3 fatty acids fed pregnant mice, 3 dams died before giving birth and 3 dams got sick after birth 
and/or died, whereas only 1 out of 9 water-fed pregnant dams got sick and died after birth with no death 
before birth. Maternal signs of sickness included lethargic behavior and lack of care for the neonates, and 
those that died or got sick were excluded from data collection for fetal and neonatal death rates.  
To assess the effects of omega-3 fatty acids on inflammatory responses induced by Listeria in vitro, 
HUVECs pre-incubated with purified omega-3 fatty acids or vehicle control were infected with L. 
monocytogenes 10403S and analyzed for inflammatory cytokines expression. IL6, MCP1, ICAM and E-
selectin were suppressed by omega-3 fatty acids compared to the vehicle control, but not IL1 , IL8 or CCL5 
(Figure 3.9C). Taken together, the results suggest that while omega-3 fatty acids partially suppress 
inflammatory responses in Listeria infection, such suppression may be harmful to the infected dams and 
their pregnancy, rather than beneficial.  
 
Discussion 
 Benefits of omega-3 fatty acids and their metabolites have been studied extensively in infectious 
diseases (Caron et al., 2015; Chiang et al., 2015; Honda et al., 2015; Sharma et al., 2013; Spite et al., 
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2009; Sun et al., 2016; Svahn et al., 2016). EPA and DHA are precursors of pro-resolving lipid mediators 
and low-inflammatory eicosanoids whose functions include modulation of trans-endothelial neutrophil 
migration, promotion of macrophage clearance of apoptotic neutrophils, and activation of anti-inflammatory 
cytokines and adhesion molecules (Calder, 2013; Fujita et al., 2011; Oh et al., 2010, 2014; Serhan, 2014; 
Serhan et al., 2008; Sethi et al., 2002). A large body of literature has demonstrated the anti-inflammatory 
properties of omega-3 fatty acids (Endo and Arita, 2016; Jordao et al., 2008; Lin et al., 2017; Yan et al., 
2013), nonetheless, some clinical trials of dietary supplementation of omega-3 fatty acids have shown no 
effect (Andrieu et al., 2017; Søyland et al., 1993; Watanabe and Tatsuno, 2017). Our results show that 
purified omega-3 fatty acids EPA and DHA suppress inflammatory responses in endothelial cells mediated 
by both TLR2 and TLR4, and protect against inflammation caused by both Gram-positive and Gram-
negative bacteria in vitro. They also protected murine fetuses against F. nucleatum infection in vivo. Many 
supplementation studies have only tested modest doses. However, the present study and other successful 
human trials suggest that doses higher than currently recommended may be necessary for special 
conditions (Dunstan et al., 2008; Gapinski, 1993; Glueck et al., 2012; Morris et al., 1993; Nestel et al., 2002; 
Vors et al., 2017).  
 Besides suppression of inflammation, omega-3 fatty acids also inhibited F. nucleatum proliferation 
in the placenta, which appeared to be secondary to the immune suppression. This is likely due to the 
inflammophilic nature of F. nucleatum. Previous studies have reported that periodontal pathogens, e.g. 
Porphyromonas gingivalis, are inflammophilic in that inflammation generates a favorable environment for 
its proliferation due to an abundance of degraded proteins and enrichment of nutrient-rich exudates (Marsh, 
2003). F. nucleatum is a strong immune stimulator (Bashir et al., 2016; Bui et al., 2016; Han et al., 2000; 
Mendes et al., 2016), consistent with the inflammophilic characteristics. Fetal protection may be a result of 
immune suppression alone or in combination with inhibition of bacterial proliferation.  
 Suppression of F. nucleatum proliferation by omega-3 fatty acids was not due to enhanced 
neutrophil activity. Neutrophils are sentinel innate immune cells that are crucial in the early eradication of 
invading pathogens and the survival of host (Craciun et al., 2010). Omega-3 fatty acids have been reported 
to modulate the neutrophil recruitment and migration to the site of inflammation (Arnardottir et al., 2013; 
Rodrigues et al., 2016; Tull et al., 2009). Arnardottir et al. showed that upon intraperitoneal injection with 
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endotoxin, total neutrophil in the blood and peritoneum increased in mice fed a diet rich in omega-3 fatty 
acids compared to control mice (Arnardottir et al., 2013). On the other hand, others have shown that omega-
3 fatty acids inhibit neutrophil adhesion to the endothelium and inhibit neutrophil infiltration across the 
endothelial cells (Tull et al., 2009; Yates et al., 2011). It seems that the effects of omega-3 fatty acids on 
neutrophil activity may depend on the immune status of the individual. Resolvin D2 (RvD2), a metabolite of 
omega-3 fatty acids, has been shown to restore the directionality of neutrophils in rats with burn injury and 
increase survival during sepsis but not in normal rats (Kurihara et al., 2013). Our preliminary study suggests 
that supplementation of omega 3 fatty acids does not increase neutrophil migration to the site of infection 
by F. nucleatum, in both the peritoneum and the placenta. Further investigation into the mechanism of the 
omega-3 fatty acids effect in F. nucleatum infection is warranted.  
 Despite the known anti-inflammatory properties of omega-3 fatty acids, supplementation with 
omega-3 fatty acids did not protect the mouse fetuses and neonates from Listeria monocytogenes infection, 
and even showed a trend of increased susceptibility in pregnant mice. Unlike F. nucleatum, L. 
monocytogenes typically infects systemic organs rather than specifically targeting placenta, and the rapid 
proliferation can lead to systemic organ dysfunction eventually killing the host. Neutrophil-mediated 
clearance of L. monocytogenes have been well established to be critical in protection against listeriosis, 
especially high-dose infections (Carr et al., 2011; Pamer, 2004). Production of TNFa by monocytes and 
dendritic cells have also been shown to be important in host defense against L. monocytogenes (Carr et 
al., 2011; Serbina et al., 2003). The suppression of inflammation by omega-3 fatty acids possibly impaired 
the innate immune response including neutrophil activation and cytokines production, and leading to 
uncontrolled proliferation of L. monocytogenes and resulting in the death of dams. Although chronic and 
dysregulated inflammation has been regarded the culprit of the “modern” diseases, such as atherosclerosis, 
diabetes and obesity, our study demonstrates that inflammation is a fundamental and critical host defense 
mechanism against various pathogenic stimuli, especially the acute infections.  
 While our study tested the combined intake of different omega-3 fatty acids—EPA and DHA—
similar to the commercial omega-3 supplements, most guidelines on dietary intake of omega-3 do not 
specify the recommended ratio of EPA and DHA (Russell and Bürgin-Maunder, 2012).  Studies have 
revealed differential efficacies of EPA and DHA in ameliorating cardiometabolic risk factors (Allaire et al., 
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2017) and related diseases such as  hypertention (Rousseau-Ralliard et al., 2009) and platelet activation 
(Phang et al., 2009), neurodegenerative disorders (Dyall, 2015), depression (Martins, 2009), and 
rheumatoid arthritis (Morin et al., 2015). Whether the effects of EPA and DHA are shared, or differential, or 
complementary depend on the disease type and mechanism (Mozaffarian and Wu, 2012; Russell and 
Bürgin-Maunder, 2012). The differential regulation of transcription factors, incorporation into cellular 
membrane, and types of metabolites of EPA and DHA contribute to the differential effects (Russell and 
Bürgin-Maunder, 2012). In terms of pregnancy, few studies tested the effect of EPA and DHA separately 
on pregnancy outcomes. One secondary analysis study revealed that EPA-rich but not DHA-rich prenatal 
supplementation resulted in reduced concentration of cytokines IL6 and TNFa in the maternal blood 
(Mozurkewich et al., 2018). An animal study showed that in fetal lamb pulmonary circulation, EPA but not 
DHA infusion improved symptoms of experimental pulmonary hypertension of the newborn (Sharma et al., 
2017). While these results suggest benefit of EPA rather than DHA during pregnancy, studies on DHA 
supplementation alone have revealed that DHA may prolong gestation (Makrides et al., 2010; Smuts et al., 
2003). Due to the differential effects of EPA and DHA and lack of consensus in their effects on pregnancy, 
it may be of interest to test EPA and DHA separately for prevention of infection-induced APO, especially 
those involving F. nucleatum.  
 The notion that omega-3 fatty acids may protect against bacterial infection during pregnancy is very 
exciting, especially because there are no safe prophylactic therapies currently available. Given that 
intrauterine infection may occur at any point during pregnancy, continuous use of antibiotics for preventive 
purpose is impractical. Dietary supplementation of omega-3 fatty acids has been recommended to pregnant 
women for its benefits in preventing maternal depression and facilitating fetal growth and childhood 
neurologic and immune development (Best et al., 2016; Bourre, 2007; Gould et al., 2013). Our results 
suggest that it may protect against APO. Previous studies suggest that a variety of oral bacteria may 
colonize the placenta through hematogenous translocation (Aagaard et al., 2014; Fardini et al., 2010; Han 
et al., 2006). Our study demonstrates that omega-3 fatty acids suppress endothelial inflammatory 
responses caused by both Gram-positive and Gram-negative bacteria, but not in sepsis-causing bacteria 
such as Listeria. Future studies should examine the effects of omega-3 fatty acids in reducing APOs caused 

















Figure 3.1. Purified omega-3 fatty acids suppress endothelial inflammation induced by F. 
nucleatum. Purified omega-3 (300 μM or 600 μM) or omega-6 fatty acids (600 μM) were complexed with 
fatty acid–free BSA at a molar ratio of 4:1 and preincubated with HUVECs for 3 hours prior to bacterial 
infection. Log-phase F. nucleatum 12230 was incubated with primary HUVECs at an MOI of 50:1 for 24 
hours. Levels of mRNA were measured by real-time quantitative PCR and are expressed as fold change 
compared to the uninfected control group. Each experiment was performed in triplicates and repeated at 
least 3 times. The results are presented as dot plots with average and SEM. One-way ANOVA was 































































































































































Fn + omega-3 (300uM)
Fn + omega-3 (600uM)





















































































































































































































































































































Figure 3.2 Purified omega-3 fatty acids suppress endothelial inflammation induced by both Gram-positive and 
Gram-negative bacteria. Purified omega-3 (300uM or 600uM) or omega-6 fatty acids (600uM) were complexed with 
fatty acid-free BSA at a molar ratio of 4:1 and pre-incubated with HUVEC for 3 hrs prior to bacterial infection. A. Log-
phase S. aureus (CA-MRSA LAC-USA 300) was incubated with HUVEC at an MOI of 10:1 for 6 hours. B. LPS (1 
ug/mL) or Pam3CSK (10 ug/mL) were incubated with HUVEC for 24 hrs. Levels of mRNA were measured by real-time 
quantitative PCR, expressed in fold change compared to the uninfected control group. Each experiment was performed 
in triplicates and repeated at least three times. The results are presented as dot plots with average and SEM. One-way 














Figure 3.3. Effects of omega-3 fatty acids on body weight of pregnant C57BL/6 mice. Body weights 
of pregnant C57BL/6 mice gavaged with omega-3 oil (33 mg omega-3 fatty acids in 100 uL every other 
day) (n=10) or water (n=10) were measured E1, E7 and E16 during gestation. The results are presented 
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Figure 3.4. Omega-3 fatty acids reduce F. nucleatum–induced fetal and neonatal death, placental 
inflammation, and bacterial proliferation. Inbred C57BL/6 mice and outbred CF-1 mice were gavaged 
with fish oil (C57BL/6: 33 mg of omega-3 fatty acids in 100 uL of commercial fish oil every other day; CF-1: 
3, 16, 33mg of omega-3 fatty acids in 10, 50, 100 uL every day) from day 1 to day 16 of gestation by oral 
gavage. Control group received water (C57BL/6), or nothing (CF-1) throughout the gestation starting day 1 
through day 16 or 17, when approximately 107 CFU of F. nucleatum 12230 or saline was injected via tail 
vein. (A and C) Fetal and neonatal death rates of C57BL/6 (A) and CF-1 mice (C). Death rates are 
expressed as the percentage of dead fetus and neonates of each litter at birth and followed through 3 days 
after birth. Each geometric symbol represents 1 pregnant mouse. Treatment is listed below the x axis. The 
horizontal lines indicate the average death rates, and error bars represent SEM. (B and D) Placental 
inflammatory mRNA gene expression levels in C57BL/6 (B) or CF-1 mice (D) at 48 hours after injection. 
Gene expression is presented as fold change in comparison to the saline-injected controls, with average 
and SEM. At least 5 pregnant mice were included in each group. (E and F) Live F. nucleatum titers in the 
placentas of C57BL/6 (E) or CF-1 mice (F) at 48 and 72 hours (E) or 24, 48, and 72 hours (F) after injection 
are expressed as log(CFU/gram tissue). At least 3 pregnant mice were included in each group. The results 
are presented as dot plots, with average and SEM. Mann-Whitney test (A) or 2-way ANOVA with simple-
effects analysis (B–F) was performed. Student-Newman-Keuls was applied for post-hoc comparisons. *P 













Figure 3.5. Growth of F. nucleatum 12230 with or without omega-3 fatty acids. F. nucleatum 12230 
were grown in Columbia broth supplemented with or without purified ω-3 fatty acids (600uM) complexed 















Figure 3.6. Bacterial proliferation in TLR4-/- mouse placentas. Pregnant C57BL/6 TLR4-/- mice were 
gavaged with water or fish oil (33 mg omega-3 fatty acids in 100 uL) from day 1 through day 16 or 17 of 
gestation, when approximately 107 CFU of live F. nucleatum were injected into tail vein. The live F. 
nucleatum titers in the placenta, expressed as Log(CFU per gram tissue) (y-axis), were determined at 48 
and 72 hours post injection by colony counting on blood agar plates. At least 3 pregnant mice were included 





























Figure 3.7. Purified omega-3 fatty acids increase IL8 transcription in HUVECs infected with F. 
nucleatum. Purified omega-3 (300 μM or 600 μM) or omega-6 fatty acids (600 μM) were complexed with 
fatty acid–free BSA at a molar ratio of 4:1 and preincubated with HUVECs for 3 hours prior to bacterial 
infection. Log-phase F. nucleatum was incubated with primary HUVECs at an MOI of 50:1 for 1 hour. Levels 
of mRNA were measured by real-time quantitative PCR and expressed as fold change compared to the 
uninfected control group. Each experiment was performed in triplicates and repeated at least 3 times. The 
results are presented as dot plots with average and SEM. One-way ANOVA was performed with Bonferroni 
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Figure 3.8. Omega-3 fatty acids do not increase neutrophil infiltration to the site of F. nucleatum 
infection. (A) Gating strategy of flow cytometry analysis for neutrophils. Single cells were gated by 
aggregate exclusion (1), immune cells were gated using CD45 marker (2), and neutrophils were gated 
using Ly6G marker (3). (B-D) Percentage of neutrophils over all infiltrating immune cells. (B) Non-pregnant 
C57BL/6 mice were gavaged with fish oil or nothing every other day for two weeks until day 16, when 
approximately 10
7
 CFU of F. nucleatum 12230 was injected intraperitoneally. Single cells were collected 
from the peritoneum and stained for CD45 and Ly6G and analyzed by flow cytometry. (C and D) Pregnant 
C57BL/6 mice were gavaged with fish oil (n=3) or water (F. nucleatum: n=3; saline: n=2) every other day 
for two weeks until day 16, when approximately 10
7
 CFU of F. nucleatum 12230 or saline was intravenously 
injected. Single cells from the pooled placentas were collected by enzymatic digestion, then stained with 
CD45 and Ly6G antibodies and analyzed by flow cytometry. (C) Representative flow cytometry scatter plots 
of CD45+/Ly6G+ population over CD45+ population. (D)  Average percentage of (C) ± SEM. One-way 
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Figure 3.9. Omega-3 fatty acids does not affect L. monocytogenes–induced fetal and neonatal death 
but increases maternal mortality by suppressing inflammation. (A) and (B) C57BL/6 mice were 
gavaged with fish oil (33mg omega-3 fatty acids in 100 uL) (n=14) or water (n=9) throughout the gestation 
starting day 1 through day 16 or 17, when approximately 10
8
 CFU of L. monocytogenes 10403S or PBS 
was gavaged. (A) Effect of omega-3 fatty acids on fetal and neonatal death. Death rates are expressed as 
the percentage of dead fetus and neonates of each litter at birth and up to 3 days after birth. Each geometric 
symbol represents 1 pregnant mouse. Treatment is listed below the x axis. The horizontal lines indicate the 
average death rates, and error bars represent SEM. Data from dams that got sick or died due to the infection 
were excluded from the analysis. (B) Effect of omega-3 fatty acids on dam survival. Dams were followed 
up to 7 days post infection. Mantel-Cox test was used for curve comparison (p=0.112). (C) Purified omega-
3 faty acids (600 μM) were complexed with fatty acid–free BSA at a molar ratio of 4:1 and preincubated 
with HUVECs for 3 hours prior to bacterial infection. Log-phase L. monocytogenes 10403S was incubated 
with primary HUVECs for 4.5 hour at MOI of 100:1. Levels of mRNA were measured by real-time 
quantitative PCR and are expressed as fold change compared to the uninfected control group. Each 
experiment was performed in triplicates and repeated 3 times. The results are presented as dot plots with 
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Chapter 4: Conclusions and future directions 
Adverse pregnancy outcomes being caused by oral bacterial infection is no longer a hypothesis 
waiting to be proven. In this body of work, we have utilized an existing model of Fusobacterium nucleatum 
placental infection to delineate the inflammatory mechanism behind the detrimental fetal death outcome. 
We have also tested an anti-inflammatory agent, omega-3 fatty acids, as a preventative therapy. In this 
chapter I summarize our findings and discuss the results collectively, as well as suggesting future directions. 
 
Placental colonization by F. nucleatum 
 Our model of F. nucleatum infection in pregnant mice has shown an organ-specific colonization of 
the placenta and clearance in other typically infected organs such as the liver and the spleen (Han et al., 
2004). Live F. nucleatum actively proliferate in the placenta, specifically throughout the decidual 
compartment, and eventually spread to the fetal membrane and the amniotic fluid. We have further shown 
that the proliferation of F. nucleatum in the placenta may depend on inflammatory microenvironment due 
to the inflammophilic nature of the microorganism as evidenced by reduced proliferation in immunodeficient 
(TLR4-deficient) and immunosuppressed (omega-3 supplemented) mice. The spatial confinement of F. 
nucleatum colonization and proliferation in the decidua implicates it as a potential target for therapeutic as 
well as mechanistic studies in the future. The inflammophilic properties of F. nucleatum is also an interesting 
area for further investigation especially in light of its association with many other extra-oral infections and 
inflammation including colorectal cancer and atherosclerosis.  
An interesting yet controversial new area of research is the placental microbiome. A few years ago, 
the Aagard group has reported that the placenta, previously thought sterile, has a low-abundant microbiome 
with a high similarity to the oral microbiome, and that the placental microbiome of preterm patients with 
chorioamnionitis harbors oral commensal bacteria such as Fusobacterium spp. and Streptococcus 
thermophiles (Aagaard et al., 2014; Prince et al., 2016). As discussed earlier, F. nucleatum has shown an 
organ-specific colonization of the placenta in our acute infection model; therefore, it is reasonable to 
hypothesize that F. nucleatum found in the placenta microbiome originates from the oral cavity by dental 
bacteremia. F. nucleatum has been shown to coaggregate with a variety of bacterial species including 
noninvasive ones (Edwards et al., 2006), so it may be of interest to investigate whether F. nucleatum 
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coaggregates with and transport the other oral species to the placenta. The idea of a placental microbiome 
suggests that pregnant women may acquire F. nucleatum and other bacteria in the placenta at any time 
during the pre- and perinatal period. The remaining question is when and what triggers the sudden 
proliferation of F. nucleatum in the placenta to lead to the detrimental inflammation. Our study suggests 
that acute infection is one of such triggers, and that depending on the timing and the severity of the infection, 
the outcome may range from miscarriage to preterm birth to even stillbirth. Alternatively, there may be a 
threshold of F. nucleatum in the placenta that the immune surveillance can tolerate, and when surpassed, 
the inflammatory responses are activated leading to adverse pregnancy outcomes. This would also explain 
why numerous studies of periodontal treatment during pregnancy have failed to effectively reduce adverse 
pregnancy outcomes, as the timing and the target location of the intervention would differs from the typical 
periodontal care, but rather a continuous monitoring of the placental microbiome. 
 
Placental inflammatory pathways 
A sign of placental inflammatory response against F. nucleatum infection was detected as early as 
30 minutes after infection in the decidual endothelial cells, hallmarked by the nuclear translocation of p65 
subunit of the NF-kB transcription factor. This was exciting as it clearly shows the very first line of response. 
The nuclear NF-kB localization was detected to spread over time from the endothelial cells to the 
spongiotrophoblast cells surrounding the blood vessels, then disappeared six hours after infection. The 
nuclear translocation of NF-kB is one of the earlier events downstream of TLR4 pathway upon detection of 
PAMPs. The transcription factor activates the synthesis of proinflammatory cytokines and chemokines to 
initiate inflammatory response, and indeed we detected the mRNA expression of inflammatory genes at 24 
and 48 hours after infection.  
Significantly increased levels of IL1b protein was also detected at 48 hours after infection. IL1 family 
cytokines, including IL1a, IL1b, IL18, IL33, and IL36, are one of the first cytokines produced during infection, 
and are the amplifiers of inflammation (Afonina et al., 2015). They are produced as inactive pro-forms and 
require cleavage by proteases to become active. The best studied amongst such proteases is caspase-1, 
which needs to be activated by a protein complex named inflammasome. While IL1b protein was detected 
by ELISA and IHC at 48 hours after infection, the antibodies were not specific to the active form ,therefore 
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the data could not distinguish if the detected proteins were active. With the evidence of significant 
inflammation hallmarked by preterm birth and fetal death, we can only assume that the proteins are active. 
Nonetheless, despite the apparent induction of IL1b in the placental inflammatory response, our results 
suggest that NLRP3 inflammasome is unlikely involved in the early processing IL1b, as the significant 
transcription of NLRP3 only occurred after 72 hours of infection, long after the first detection of IL1b mRNA 
at 24 hours after infection. Alternatively, pro-IL1b can be processed by extracellular proteases released 
commonly by neutrophils (Clancy et al., 2018). The extracellular proteases are postulated to be 
endocytosed into the endothelial or other infected cells to cleave IL1b (Houghton et al., 2010). Neutrophil 
elastase, cathepsin G, and proteinase 3 have been shown to activate IL1b, especially in neutrophil-
mediated inflammatory diseases (Alfaidi et al., 2015; Coeshott et al., 1999; Joosten et al., 2009). We could 
hypothesize that neutrophil infiltration to the site of infection is required for IL1b production. To date, the 
earliest we have observed neutrophil infiltration and tissue necrosis is 48 hours post injection, but earlier 
time points were never tested. It would be of interest, especially considering that neutrophils are the first 
responders to infection, to examine the kinetics of neutrophil response with respect to the inflammatory 
cascade. Depletion of neutrophils, or inhibition of the neutrophil proteases and caspase-1 as a control may 
elucidate the true culprit of IL1b response to F. nucleatum infection. 
Understanding the respective contribution of maternal versus fetal response in PTB is critical for 
developing preventive strategies against the early onset of labor and delivery. We have identified the 
maternal decidua as the site of bacterial colonization, and the endothelium as the origin of the inflammation. 
By utilizing a genetic model where the maternal and fetal compositions of TLR4 gene are different, we have 
shown that in the absence of maternal or endothelial TLR4, there is neither maternal- nor fetal-derived 
placental inflammatory response despite the bacterial colonization. These results demonstrate that 
maternal initiation of placental inflammation is the cause of fetal demise. 
The mechanism by which endothelial TLR4 signaling affects the inflammatory cascade warrants 
further investigation. Endothelial cells are the first line of defense in our model, and are possibly releasing 
cytokines and chemokines to promote the recruitment and adhesion of neutrophils to the placenta. This is 
unique in that typically microbial invasions are detected by both endothelial cells and tissue-resident 
macrophages, which was ruled out when our results showed hematopoietic TLR4 deficient mice responding 
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no different to the infection as the wildtype. Additionally, a lack of neutrophil infiltration during F. nucleatum 
infection in the placentas of TLR4 deficient mice has been reported (Liu et al., 2007). It would be of interest 
to see whether endothelial TLR4 deficiency will also result in the lack of neutrophil infiltration, which would 
suggest whether or not the neutrophils are recruited by signals generated either directly or indirectly from 
the endothelial cells. 
 
Omega-3 fatty acids and the anti-inflammatory mechanism 
Omega-3 fatty acids exert anti-inflammatory effect in placental inflammation induced by F. 
nucleatum. The anti-inflammatory mechanism by omega-3 fatty acids differs by the inflammatory stimuli 
and the tissue and cell types. Omega-3 fatty acids have been shown to have bactericidal effect on 
planktonic bacteria (Sun et al., 2016), modulate the migration (Arnardottir et al., 2013; Rodrigues et al., 
2016; Tull et al., 2009) and bactericidal function (Pisani et al., 2009) of neutrophils, regulate endothelial 
adhesion interaction with immune cells (Goua et al., 2008; Yates et al., 2011), and suppress expression of 
inflammatory cytokines and chemokines (Lin et al., 2017; Liu et al., 2015; Williams-Bey et al., 2014). In the 
context of placental inflammation, inhibition of inflammasome activation and IL1b release by omega-3 fatty 
acids in decidual cells and trophoblasts has been reported in vitro (Chen et al., 2018; Roman et al., 2006). 
One or more of the above-mentioned mechanisms may contribute to the observed protective effect of 
omega-3 fatty acids supplementation in our F. nucleatum infection model. We have confirmed that there is 
no bactericidal effect of omega-3 fatty acids on F. nucleatum in vitro but observed a suppression of 
inflammatory cytokines and chemokines expression in endothelial cells in vitro as well as in infected 
placenta in vivo. We also detected increased neutrophil infiltration into the infected placenta. However, 
there are gaps in knowledge. We don’t know what increased neutrophil infiltration, e.g., increased 
expression of adhesion receptors on neutrophils or endothelial cells, or both. Whether the bactericidal 
function of neutrophils is enhanced is also of question. Last but not of least importance, an explanation to 
the resolution of neutrophil-mediated inflammation must be provided, as neutrophils notoriously damage 
the host by its proteases, reactive oxygen species, and neutrophil extracellular trap. Typically, excessive 
recruitment of neutrophils leads to tissue damage for this reason. Therefore, in the current scenario where 
increased neutrophil infiltration is accompanied by suppression of inflammation, promoting efficient cell 
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death and clearance of neutrophils after clearing the bacteria is critical for successful resolution of 
inflammation. Promotion of neutrophil apoptosis by omega-3 fatty acids-derived molecules as a means of 
resolution of inflammation has been well described (El Kebir and Filep, 2013; El Kebir et al., 2012). 
Additionally, some studies have shown omega-3 fatty acids-mediated enhancement of autophagy in cancer 
cells as well as in neutrophils (Rovito et al., 2015; Shin et al., 2013; Williams-Bey et al., 2014). Future 
studies should test the effect of omega-3 fatty acids on not only the chemotaxis and bactericidal activities 
but also the clearance of neutrophils.  
 
Concluding remarks 
In this study, we identified the maternal endothelium as the origin of, and the TLR4-TRIF signaling 
cascade as the signaling pathway leading to F. nucleatum-induced placental inflammation and adverse 
pregnancy outcomes. We suggest the endothelial activation of neutrophil recruitment, and the subsequent 
antimicrobial activity of the neutrophils in the placenta, as the main effector of placental inflammation. 
Further in-depth comparison of the transcriptomes of the infected and non-infected placentas, as well as 
the neutrophil depletion assay, should be conducted in future investigation. In addition, we have revealed 
the anti-inflammatory and anti-microbial effects of omega-3 fatty acids in F. nucleatum infected mice. 
Modulation of neutrophil recruitment, function and resolution may be possible underlying mechanisms for 
the protective effect. Understanding the nature of inflammation enables therapeutic development to combat 
the undesired outcomes. Our study provides a fundamental ground for understanding the etiology of 
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Appendix I: Preliminary transcriptomic analysis reveals possible 




 With the recent development in bioinformatics, technologies for transcriptomic investigation such 
as microarray and RNA-seq have been widely used to study the mechanism of various diseases. 
Transcriptomic analyses of human gestational tissues collected from term and preterm deliveries have 
reported predominant inflammatory activation in the myometrium and the decidua (Mittal et al. 2010; Weiner 
et al. 2010; Bukowski et al. 2017; Eidem et al. 2015; Stephen et al. 2015; Rinaldi et al. 2017). However, 
systematic reviews report that the detailed differentially expressed gene profiles comparing gestational 
tissues of preterm and term birth cases are inconsistent due to the complexity of causes of PTB as well as 
multiple maternal and fetal tissues involved in parturition (Eidem et al. 2015). In addition, to date there is 
no study specifically focusing on the placental gene expression profiles during intrauterine infection. 
Therefore, we performed RNA-seq analysis of murine placentas infected with Fusobacterium nucleatum. 
 
Materials and Methods 
Bacterial strain and maintenance 
Fusobacterium nucleatum 12230 was maintained at 37ºC under anaerobic condition (90% N2, 5% 
CO2, 5% H2), in Columbia broth (Becton Dickinson, Franklin Lakes, NJ) or Tryptic Soy Agar (TSA, Becton 
Dickinson, Franklin Lakes, NJ) blood plates (5% sheep blood), all supplemented with 5 ug/mL hemin and 
1 ug/mL menadione (Han et al. 2006).  
Mouse strain and husbandry 
Wild type C57BL/6 mice were purchased from the Jackson Laboratory (Bar Harbor, ME) and bred 
in-house. All mice were kept in sterilized filtered-topped cages with 12-hour light cycle, fed autoclaved food 
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(Pico Lab Mouse Diet 20 No. 5058; 22 kcal% fat, 55 kcal% carbohydrate, and 23 kcal% protein) and water 
ad libitum, and handled in a laminar flow hood. The animal protocol was approved by the Columbia 
University Institutional Animal Care and Use Committee (New York, NY).  
 
Mating and i.v. injection of mice 
Mating was conducted as previously described (Han et al. 2004). Briefly, mice 10-12 weeks old 
were caged together at a female-to-male ratio of 2:1. Mating was determined by the presence of a white 
vaginal plug. The day when the plug was detected was designated as day 1 of gestation. Mice were 
randomly distributed to study groups.  
Pregnant mice were injected with approximately 107 CFU of F. nucleatum on day 16 or 17 of 
gestation as described previously (Han et al. 2004). F. nucleatum 12230 was cultured to exponential growth 
phase. Following centrifugation, the bacteria were suspended (without washing) in sterile PBS at an 
estimated concentration of 108 CFU/mL. The actual dose was determined by spotting serial dilutions of the 
prepared suspension on blood agar plates. A maximum volume of 100 µL was injected into the tail vein of 
the pregnant mice. The infected mice were sacrificed at indicated times for RNA extraction. The decidua 
was separated from the rest of the placenta by peeling off with forceps.  
 
RNA extraction and quality control  
RNA was extracted from mouse placental tissues, mechanically disrupted by mashing in blender 
bag and passing through 22G needle and syringe, then followed by the Qiagen RNeasy Mini Kit I according 
to the manufacturer’s protocol (Qiagen #74106). (DNase I treatment was unfortunately not performed.) The 
quantity and the 260/280 ratio of extracted RNA were measured using a NanoDrop ND 1000 
spectrophotometer (NanoDrop Technologies). The integrity of the extracted RNA was assessed using The 
Agilent 2011 Bioanalyzer System (Agilent). Following the automatic calculation by the Bioanlalyzer 
software, each sample was given an RNA integrity number (RIN), a number between 1 and 10, with 1 being 
the most degraded and 10 being the most intact (Schroeder et al. 2006). The RNA quantity, 260/280 ratio, 




Real-time quantitative PCR 
Complementary DNA (cDNA) was synthesized by reverse transcription (RT) PCR using the 
Superscript IV First-Strand Synthesis System (Invitrogen, #18091050) according to the manufacturer’s 
instructions. For controls without RT, the reverse transcriptase was replaced with an equal volume of water. 
Real-time quantitative PCR was performed in duplicates, using StepOnePlusTM (Applied Biosystems). Each 
reaction was prepared with Power SYBR® Green PCR Master Mix kit according to the manufacturer’s 
instructions (Applied Biosystems). Specific primers of β-actin (Forward: GGCTGTATTCCCCTCCATCG, 
Reverse: CCAGTTGGTAACAATGCCATGT) were added at a final concentration of 500 nM. PCR 
amplifications were performed with initial step at 95°C for 10 minutes; followed by 40 cycles of 95°C for 30 
seconds, 59°C for 30 seconds, and 72°C for 30 seconds; then a melt curve stage of 95°C for 15 seconds, 
60°C for a minute and 95°C for 15 seconds. The results were expressed by the mean Ct value.  
 
RNA sequencing and data analysis 
 
The library preparation and the RNA sequencing were carried out at JP Sulzberger Columbia 
Genome Center. Removal of rRNA was performed with Ribo-Zero rRNA removal kit (Illumina), followed by 
library preparation with Truseq Stranded Total RNA Kit (Illumina). The total RNA sequencing was performed 
on Illumina HiSeq 2500 with 40 million pair-end reads.   
Reads were aligned to the mm10 assembly of the mouse genome using STAR (Dobin et al. 2013) 
and RNA expression was quantified on a gene-level using featureCounts (Liao et al. 2014). Raw counts of 
all observed genes were normalized with the trimmed mean method (Robinson and Oshlack 2010) and 
subjected to the log2(Counts+1) transformation. Differential expression was analyzed using weighted 
Limma-Voom (Ritchie et al. 2015; Law et al. 2014; Liu et al. 2015). Five comparisons were performed:  
infected vs uninfected decidua (Comparison 1: C1), infected vs uninfected non-decidua (C2), uninfected 
decidua vs uninfected non-decidua (C3), infected decidua vs infected non-decidua (C4), and (uninfected 
decidua vs infected non-decidua) vs (uninfected non-decidua vs infected non-decidua) (C5) (Table 2). 
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C5 represents how the effect of infection on non-decidua differs from its effect on decidua. The 
number of differentially expressed genes (DEGs) in C1, C2 and C5 are suitable for meaningful 
overrepresentation analysis in terms of Gene Ontology (Ashburner et al. 2000) Categories and KEGG 
Pathways (Kanehisa et al. 2004) (Table 2). The number of DEGs in C3 and C4 are too large. We used a 
significance cutoff of raw p <0.001 for the differential expression of each gene, as input to the Gene 
Ontology and pathway analyses of C1, C2, and C5. C1, C2 and C5 were analyzed in terms of the Biological 
Process Gene Ontology, using the Elim method (Alexa et al. 2006), as implemented in iPathwayGuide 
(Tarca et al. 2009; Draghici et al. 2007). C1, C2 and C5 were also analyzed in terms of KEGG pathways 
with iPathwayGuide. Finally, C1, C2 and C5 were analyzed in terms of Reactome pathways (Croft et al. 
2011) using overrepresentation analysis as implemented in WEBGESTALT (Liao et al. 2019). 
 
Hierarchical clustering for heatmap analysis 
100 genes with false discovery rate (fdr) <0.05 in the comparison groups of Infected decidua vs 
Uninfected decidua (C1) and Infected non-decidua vs Uninfected non-decidua (C2), were selected based 
on their relevance to response to infection as well as absolute fold changes. Of these, 119 genes were 
non-redundant. The expression of these genes were subject to hierarchical clustering (Eisen et al. 1998; 
Everitt et al. 2011), by both genes and samples. The expression of each gene was mean-centered (Eisen 
et al. 1998). Distances were based on the Pearson correlation coefficient and average-linkage clustering 
was used (Eisen et al. 1998; Everitt et al. 2011). Clustering was performed, and a dendrogram and the 






Transcriptomic analysis of F. nucleatum-infected decidua and non-decidua presents unique 
inflammatory gene profiles compared to the respective non-infected controls 
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RNA-seq was performed to investigate the differential transcriptomic expression of the placentas 
infected with F. nucleatum and the uninfected controls, and the pathogenic pathways that may be activated 
leading to adverse pregnancy outcome. Wild type mice were injected with approximately 107 CFU of F. 
nucleatum 12230 or saline, and placentas were collected at 72 hours after injection. Placentas were 
separated into two compartments by peeling off the decidua (D) from the rest, termed non-decidua (ND). 
Differential expression analyses were performed for five comparison pairs (Table 2). Comparison 1 (C1: 
infected D vs. control D) and comparison 2 (C2: infected ND vs. control ND) are reported, along with the 
overexpression analyses of differentially expressed genes (DEGs) in Biological Process Gene Ontology 
(GO) terms and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways.  
In C1, a total of 150 DEGs were identified with a cutoff p-value of 0.001. Among the DEGs, the top 
20 genes based on absolute fold changes were those involved in innate immune responses (Ccl20, Dio3, 
Dpp6, Ngf4, Thrsp, Tagln, Oxtr, Lsp1), muscle contraction (Myocd, Myh11, Actg2, Kcnmb1, Kcnma1, Cnn1, 
Oxtr), and extracellular matrix (ECM) organization (Col11a1, Col6a4) (Table 3). Overexpression enrichment 
analysis showed that these DEGs were enriched in GO terms involved in the migration and activation of 
immune cells especially neutrophils and T cells, immune response to infection such as complement 
activation and cytokines biosynthesis, endothelial angiogenesis, and uterine contraction (Tables 4). KEGG 
analysis revealed that DEG enrichment in biological pathways was in agreement with the GO analysis 
(Table 5). For example, pathways involved in immune cell migration such as ECM-receptor interactions, 
protein digestion and absorption, and focal adhesion, and pathways involved in inflammatory response 
such as phagosome and complement cascade activation were enriched. The DEGs in these categories 
were mostly upregulated, suggesting an active immune response and uterine contraction in the decidua 
(Figure 1).  
 C2 resulted in 578 DEGs. This trend is also reflected in the DEGs with top 20 genes with the highest 
absolute fold changes, where only two genes had positive fold change (Table 6). While some DEGs-
enriched GO terms and KEGG pathways were related to immune response and uterine contraction, many 
terms were associated with metabolism (Table 7 and 8). In contrast to the responses in the decidua, the 




Decidua responds differently to F. nucleatum infection compared to non-decidua 
Because F. nucleatum colonization and proliferation is confined to the decidua, and because 
maternal rather than paternal TLR4 induces placental inflammation, we compared the inflammatory gene 
expressions in the decidua and non-decidua. Of the total of 150 DEGs in the decidua (C1), 110 were 
upregulated and 40 were downregulated in the infected decidua compared to the uninfected controls 
(Figure 1). In contrast, 479 of the 578 DEGs in the non-decidua (C2) were downregulated (Figure 1).  
Moreover, a dendrogram of selected genes (p<0.05) shows that the samples cluster according to the tissue 
type and infection status (Figure 2). The genes cluster into 4 main groups: non-decidua uninfected (ND-
ctrl), non-decidua infected (ND-inf), decidua uninfected (D-ctrl), and decidua infected (D-inf). The heatmap 
also shows that the response to infection in decidua and non-decidua differs for many genes; overall, the 
gene expression is lower in the infected non-decidua (ND-inf) compared to in uninfected non-decidua (ND-
ctrl), but higher or equal to in the infected decidua (D-inf) compared to infected decidua (D-inf). These 
results suggest that transcriptional responses to infection were dichotomous depending on the tissue types.  
 
Presence of genomic DNA in RNA samples may have affected the RNA-seq results 
RNA extraction carried out without DNase treatment may result in excessive amount of genomic 
DNA (gDNA) contamination. Such gDNA contamination may affect the RNA-seq by increasing the 
percentage of non-specific reads, and ultimately affect the data interpretation (Hashemipetroudi et al. 2018; 
Galiveti et al. 2010). As we did not treated our RNA samples with DNase, we tested for any trace of gDNA 
using three different methods: fluorometric measurement of double-strand DNA (dsDNA) using Qubit 
Fluorometer, computational mapping of the antisense strands and real-time quantitative PCR (qPCR) with 
template without (–) reverse transcription (RT). Fluorometric measure by Qubit showed a considerable 
amount of dsDNA (Table 1). At this time the computational mapping result is not available. 
The cycle threshold (Ct) values of qPCR performed with –RT template represents any 
contamination with gDNA, given that without RT, no cDNA should be made from RNA. We used RNA 
samples from decidua 48 hours after injection to test whether RNA without DNase I treatment has 
considerable amount of DNA (Table 9). The RNA extraction was performed in the same way as in the 
samples used for RNA-seq. Then, RT was performed with (+) and without (–) the RT enzyme, and the +RT 
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and –RT products were used for b-actin qPCR. The Ct values were compared between the qPCR performed 
with +RT and –RT. The result showed that the differences in Ct values were not substantial, indicating 
considerable gDNA contamination in the RNA samples. While the computational analysis results are not 
yet available, the results from these two methods were enough to suggest there was sufficient gDNA 




Despite the recognized gDNA contamination, the preliminary RNA-seq analysis suggests a gene 
signature of innate immune response, ECM organization and smooth muscle contraction in the infected 
compared to uninfected placentas (decidua and non-decidua combined), which possibly leads to onset of 
labor. These observations are consistent with the previous reports in transcriptomic analyses of preterm 
gestational tissues (Willcockson et al. 2018; Raymond et al. 2017; Rinaldi et al. 2017; Cheng et al. 2019). 
Clustering and heatmap analysis of select genes showed distinct expression patterns according to the 
tissue type and infection status. Comparing the GO terms and KEGG pathways enriched in the decidua 
and the non-decidua suggested that both compartments respond to infection by modulation of cell 
adhesion, ECM organization and smooth muscle contraction, but decidua more specifically in neutrophil 
and T cell activation as well as cytokines and chemokines biosynthesis, and non-decidua uniquely in lipid 
metabolism. The disparity in decidual and non-decidual response to infection is supported by the bacterial 
colonization spatially confined to the decidua and the maternal origin of inflammation as reported in the 
previous chapters. The comparison of gene expression between decidua and non-decidua suggests the 
distinctive directionality of their responses to infection. Further analysis of the DEGs dataset is necessary 
to compute the statistical clustering of enriched terms and pathways, as well as the specific DEGs involved 
in each term and pathway and the level of over- or under-expression of the individual DEGs.  
While the preliminary results of the RNA-seq analysis are exciting, we have concluded that the 
RNA-seq experiment needs to be repeated with RNA treated with DNase to eliminate gDNA. With a 
considerable amount of gDNA in the samples there may be high percentage of intergenic reads in the RNA-
seq libraries, which in the downstream analyses may result in erroneous quantitation of the transcripts and 
119 
 
affect the interpretation. We hope to avoid any doubts in the interpretation by using as clean RNA samples 




Figure 1. Venn diagrams of numbers of differentially expressed genes (DEGs) in infected decidua 
(D) and non-decidua (ND) compared to their respective uninfected controls. Wild type pregnant mice 
were intravenously injected with 107 CFU of F. nucleatum or saline on E16 of gestation (n=3 in each group). 
The decidua and the non-decidua were separated prior to RNA extraction, RNA-seq and differential 
expression analysis. A total of 150 and 578 DEGs were identified in the decidua and the non-decidua, 
respectively, based on p<0.001. The 7 overlapping genes are represented in the Venn diagram. Numbers 







Figure 2. Dendrogram and heatmap of select differentially expressed genes (DEGs) (p<0.05) in 
infected and uninfected decidua (D) and non-decidua (ND). A total of 119 genes were subject to 
hierarchical clustering with distances calculated based on the Pearson correlation coefficient and average-
linkage clustering. The genes clustered according to the four main biological groups. Gene expressions 
were log2 transformed, and values were mean centered. ND-ctrl: non-decidua uninfected control, ND-inf: 




























































































































































































































Table 1. Mouse placenta RNA and dsDNA concentrations, 260/280 ratios, RNA integrity, and Ct 
values of b-actin real-time quantitative PCR. Pregnant mice were injected via tail vein with sterile saline 
(n=3) or 107 CFU of F. nucleatum (n=3) on E16 or 17 of gestation, and the placentas were harvested at 72 
hours later. RNA was extracted without DNase I treatment. The RNA concentration and 260/280 ratio were 
measured with nanodrop, the dsDNA concentration was measured with Qubit, RNA integrity was measured 
by Bioanalyzer. Real-time quantitative PCR using b-actin primers was performed with reverse transcription. 
sample RNA ng/uL dsDNA ng/uL 260/280 RIN b-actin Ct 
+ RT – RT 
D-ctrl 336.16 33.6 2.07 2.7 22.67 N/A 
D-ctrl 246.15 29.9 2.08 2.6 22.33 N/A 
D-ctrl 245.44 30.7 2.07 2.6 23.45 N/A 
D-inf 303.5 32.5 2.06 2.7 23.92 N/A 
D-inf 318.62 31 2.06 2.2 23.54 N/A 
D-inf 149.02 21.8 2.1 2.3 23.45 N/A 
ND-ctrl 351.88 36.4 2.06 10 18.57 N/A 
ND-ctrl 364.34 36.8 2.06 8.9 19.23 N/A 
ND-ctrl 403.06 38.4 2.04 10 17.79 N/A 
ND-inf 184.21 26.2 2.1 7.9 18.61 N/A 
ND-inf 460.46 38.9 2.03 10 18.35 N/A 
ND-inf 345.75 32.4 2.07 7.3 18.06 N/A 
D: decidua 
ND: non-decidua      
ctrl: uninfected control     
inf: infected      
RIN: RNA integrity number     
Ct: cycle threshold for the fluorescent signal    




Table 2. List of comparison pairs for differential expression analysis and the number of differentially 











C5 245(Infected non-decidua VS Uninfected non-decidua) VS (Infected non-decidua VS Uninfected non-decidua)
Comparison Pairs
Infected decidua VS Uninfected decidua
Infected non-decidua VS Uninfected non-decidua
Uninfected non-decidua VS Uninfected decidua



























































































































































































































































































































































































































































































































































































































































































































































































































































































































Table 4. Selected Biological Processes Gene Ontology (GO) terms enriched by differentially 





GO ID GO Name pv_elim
GO:0002283 neutrophil activation involved in immune response 0.0086
GO:0045087 innate immune response 0.0366
GO:0002282 microglial cell activation involved in immune response 0.04
GO:0090023 positive regulation of neutrophil chemotaxis 0.0014
GO:0006958 complement activation, classical pathway 0.0008
GO:0038178 complement component C5a signaling pathway 0.0102
GO:0042104 positive regulation of activated T cell proliferation 0.0112
GO:0035709 memory T cell activation 0.0202
GO:0002572 pro-T cell differentiation 0.0301
GO:2000406 positive regulation of T cell migration 0.0325
GO:0150062 complement-mediated synapse pruning 0.0202
GO:0001525 angiogenesis 0.0378
GO:1903588 negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis 0.04
GO:0071603 endothelial cell-cell adhesion 0.0202
GO:1903588 negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis 0.04
GO:0001938 positive regulation of endothelial cell proliferation 0.0492
GO:1905563 negative regulation of vascular endothelial cell proliferation 0.0497
GO:0060087 relaxation of vascular smooth muscle 6E-05
GO:2000721
positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell 
differentiation 0.0003
GO:1904706 negative regulation of vascular smooth muscle cell proliferation 0.0005
GO:0006939 smooth muscle contraction 0.0039
GO:1904348 negative regulation of small intestine smooth muscle contraction 0.0202
GO:2000724 positive regulation of cardiac vascular smooth muscle cell differentiation 0.0202
GO:0060083 smooth muscle contraction involved in micturition 0.0301
GO:0060414 aorta smooth muscle tissue morphogenesis 0.0301
GO:0071672 negative regulation of smooth muscle cell chemotaxis 0.0301
GO:0070474 positive regulation of uterine smooth muscle contraction 0.04
GO:0071673 positive regulation of smooth muscle cell chemotaxis 0.04
GO:1904753 negative regulation of vascular associated smooth muscle cell migration 0.0497
pv_elim: p-value for gene ontology that takes into account the nested (hierarchical) structure of the gene ontology.
Table 2. Selected unique Biological Process Gene Ontology (GO) enrichment terms of differentially expressed genes




Table 5. Selected KEGG pathways enriched by differentially expressed genes (DEGs) (p<0.001) in 
F. nucleatum-infected decidua (D) compared to the uninfected controls. 
 
 
Pathway Name pv pv_fdr
ECM-receptor interaction 1.12E-08 1.04E-06
Protein digestion and absorption 1.41E-08 1.04E-06
Focal adhesion 5.67E-06 2.80E-04
Vascular smooth muscle contraction 1.14E-05 4.20E-04
Phagosome 0.0094 0.1336
Pertussis 0.0155 0.1718
Chagas disease (American trypanosomiasis) 0.0183 0.1718
Chemokine signaling pathway 0.0193 0.1718
Complement and coagulation cascades 0.0268 0.1802
C-type lectin receptor signaling pathway 0.0408 0.2415
HIF-1 signaling pathway 0.0425 0.2419
Cell adhesion molecules (CAMs) 0.0823 0.3582
Cytokine-cytokine receptor interaction 0.1052 0.3771
B cell receptor signaling pathway 0.1134 0.3771
Natural killer cell mediated cytotoxicity 0.1358 0.3914
Oxytocin signaling pathway 0.1477 0.3914
IL-17 signaling pathway 0.2468 0.4323
Apoptosis - multiple species 0.2507 0.4323
Th1 and Th2 cell differentiation 0.2536 0.4323
Fc gamma R-mediated phagocytosis 0.2570 0.4323
Human T-cell leukemia virus 1 infection 0.2670 0.4342
Th17 cell differentiation 0.2720 0.4375
T cell receptor signaling pathway 0.2818 0.4376
NF-kappa B signaling pathway 0.3438 0.4801
Tight junction 0.3634 0.4882
Wnt signaling pathway 0.3694 0.4882
TNF signaling pathway 0.3751 0.4913
NOD-like receptor signaling pathway 0.4084 0.5131
Necroptosis 0.4282 0.5195
pv: p-value taking both overrepresentation analysis and signaling into account.
Table 3. Select unique KEGG pathways different ally expressed genes (DEGs) 
























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Table 7. Selected Biological Processes Gene Ontology (GO) terms enriched by differentially 




GO ID GO Name pv_elim
GO:0001525 angiogenesis 3.80E-07
GO:0045766 positive regulation of angiogenesis 0.00081
GO:0002040 sprouting angiogenesis 0.00195
GO:0060978 angiogenesis involved in coronary vascular morphogenesis 0.02234
GO:0090049 regulation of cell migration involved in sprouting angiogenesis 0.04128
GO:0050766 positive regulation of phagocytosis 0.02137
GO:0033007 negative regulation of mast cell activation involved in immune response 0.02234
GO:0002264 endothelial cell activation involved in immune response 0.03459
GO:0002741 positive regulation of cytokine secretion involved in immune response 0.03658
GO:0006958 complement activation, classical pathway 0.00021
GO:0070488 neutrophil aggregation 0.0035
GO:0030223 neutrophil differentiation 0.02234
GO:0045586 regulation of gamma-delta T cell differentiation 0.02234
GO:0001916 positive regulation of T cell mediated cytotoxicity 0.04358
GO:0048661 positive regulation of smooth muscle cell proliferation 0.018
GO:1904707 positive regulation of vascular smooth muscle cell proliferation 0.02616
GO:0008203 cholesterol metabolic process 0.000055
GO:0042632 cholesterol homeostasis 0.0002
GO:0006695 cholesterol biosynthetic process 0.00045
GO:0010873 positive regulation of cholesterol esterification 0.00296
GO:0030299 intestinal cholesterol absorption 0.029
GO:0033488 cholesterol biosynthetic process via 24,25-dihydrolanosterol 0.03459
GO:0033490 cholesterol biosynthetic process via lathosterol 0.03459
GO:0045797 positive regulation of intestinal cholesterol absorption 0.03459
GO:0006641 triglyceride metabolic process 0.00042
GO:0097089 methyl-branched fatty acid metabolic process 0.00119
GO:0006631 fatty acid metabolic process 0.01191
GO:0030203 glycosaminoglycan metabolic process 0.0154
GO:0008202 steroid metabolic process 0.0317
GO:0006013 mannose metabolic process 0.03658
GO:0030388 fructose 1,6-bisphosphate metabolic process 0.03658
GO:0050654 chondroitin sulfate proteoglycan metabolic process 0.04358
GO:0007202 activation of phospholipase C activity 0.00551
GO:0032431 activation of phospholipase A2 activity 0.03459
pv_elim: p-value for gene ontology that takes into account the nested (hierarchical) structure of the gene ontology.
Table 5. Selected Biological Processes Gene Ontology (GO) terms enriched by differentially expressed genes (DEGs) 
(p<0.001) in F. nucleatum-infected non-deciduas (ND) compared to non-infected controls. 
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Table 8. Selected unique KEGG pathways of differentially expressed genes (DEGs) (p<0.001) 
enriched with F. nucleatum-infected non-decidua (ND) compared to uninfected controls.  
 
 
Pathway Name pv pv_fdr
Protein digestion and absorption 2.54E-08 5.53E-06
Complement and coagulation cascades 4.20E-08 5.53E-06
Steroid biosynthesis 1.67318E-06 0.0001161
Cell adhesion molecules (CAMs) 1.76576E-06 0.0001161
Hypertrophic cardiomyopathy (HCM) 8.38748E-06 0.00044118
ECM-receptor interaction 1.05022E-05 0.00046035
Renin secretion 2.81007E-05 0.00105578
Dilated cardiomyopathy (DCM) 0.000211983 0.00696893
Focal adhesion 0.000244545 0.00714614
Cholesterol metabolism 0.002195365 0.03396358
Carbohydrate digestion and absorption 0.003412599 0.04845768
Tryptophan metabolism 0.003500745 0.04845768
Ascorbate and aldarate metabolism 0.003821809 0.05025679
Vascular smooth muscle contraction 0.007489049 0.08206749
Regulation of actin cytoskeleton 0.008302713 0.08734454
Fat digestion and absorption 0.009177201 0.09273723
Phagosome 0.031721695 0.18413979
Butanoate metabolism 0.036385008 0.20360122
Fatty acid metabolism 0.037245274 0.20407306
Antigen processing and presentation 0.067019981 0.28415282
Fatty acid biosynthesis 0.078924234 0.30951894
IL-17 signaling pathway 0.080027711 0.30951894
Fructose and mannose metabolism 0.098628609 0.33687434
Glycolysis / Gluconeogenesis 0.102716786 0.34633993
Metabolic pathways 0.109434699 0.35976657
Intestinal immune network for IgA production 0.127545303 0.38579157
Regulation of lipolysis in adipocytes 0.183025379 0.46605836
Progesterone-mediated oocyte maturation 0.198692686 0.4929828
Adherens junction 0.202953323 0.49884789
mTOR signaling pathway 0.208562078 0.50322777
Peroxisome 0.260965631 0.54370169
Leukocyte transendothelial migration 0.440698404 0.71719317
Cytokine-cytokine receptor interaction 0.469756661 0.72586786
Toll-like receptor signaling pathway 0.499652163 0.7341258
T cell receptor signaling pathway 0.516704571 0.75079172
Thyroid hormone signaling pathway 0.5730047 0.80677672
Apoptosis 0.688413584 0.87044602
Bacterial invasion of epithelial cells 0.811203327 0.931644
TNF signaling pathway 0.821128545 0.93894264
Th1 and Th2 cell differentiation 0.829755109 0.9405223
Chemokine signaling pathway 0.833238389 0.9405223
Tight junction 0.845253893 0.94333207
VEGF signaling pathway 0.86687343 0.9460071
Natural killer cell mediated cytotoxicity 0.888595715 0.95778964
NOD-like receptor signaling pathway 0.921728135 0.97107792
NF-kappa B signaling pathway 0.99061104 0.99513002
Table 6. Selected unique KEGG pathways of differentially expressed genes (DEGs) (p<0.001) 
enriched in F. nucleatum-infected non-deciduas (ND) compared to non-infected controls. 
pv: p-value taking both overrepresentation analysis and signaling into account.
pv_fdr: false discovery rate  taking both  overrepresentation  analysis and signaling into account.
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Table 9. Mouse placenta RNA concentrations, 260/280 ratios, and Ct values of b-actin real-time 
quantitative PCR. Pregnant mice were injected via tail vein with sterile saline (n=3) or 107 CFU of F. 
nucleatum (n=3) on E16 or 17 of gestation, and the placentas were harvested at 48 hours later. The decidus 
was separated from the rest of the placenta by peeling off with forceps. RNA was extracted without DNase 
I treatment. The RNA concentration and 260/280 ratio were measured with nanodrop. Real-time 
quantitative PCR using b-actin primers was performed with (+) or without (–) reverse transcription (RT). 
sample RNA ng/uL 260/280 b-actin Ct 
+ RT – RT 
D-ctrl 319.91 2.06 23.00 28.71 
D-ctrl 299.19 2.05 22.93 28.39 
D-ctrl 360.9 2.03 20.75 27.97 
D-inf 310.84 2.05 21.31 26.99 
D-inf 284.2 2.05 26.04 26.81 
D-inf 287.5 2.09 20.66 28.86 
D: decidua  
ctrl: uninfected control 
inf: infected  
Ct: cycle threshold for the fluorescent signal  
RT: reverse transcription 
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Fusobacterium nucleatum is an oral anaerobe prevalent in intrauterine infection associated
with a wide spectrum of adverse pregnancy outcomes. We demonstrate here that F.
nucleatum triggers placental inflammation through maternal, rather than paternal, TLR4-
mediated signaling. Elimination of TLR4 from maternal endothelial cells alleviated placental
inflammation and reduced fetal and neonatal death, while elimination of TLR4 in the
hematopoietic cells had no effect. The placental inflammatory response followed a
spatiotemporal pattern, with NF-kB activation observed first in the maternal endothelial cells
and then in the decidual cells surrounding the endothelium, followed by induction of
inflammatory cytokines and chemokines. Supplementation of pregnant mice with fish oil as
a source of omega-3 fatty acids suppressed placental inflammation, reduced F. nucleatum
proliferation in the placenta, and increased fetal and neonatal survival. In vitro analysis
illustrates that omega-3 fatty acids inhibit bacterial-induced inflammatory responses from
human umbilical cord endothelial cells. Our study therefore reveals a mechanism by which
microbial infections affect pregnancy and identifies a prophylactic therapy to protect against
intrauterine infections.
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Introduction
Intrauterine infection is a leading cause of  adverse pregnancy outcomes (APOs), including preterm birth, 
stillbirth, neonatal sepsis, etc. Fusobacterium nucleatum is among the most prevalent microorganisms in 
intrauterine infection; it is implicated in 10%–30% of  preterm births, with its detection inversely related to 
the gestational age at birth (1–7). Bacteria detected in intrauterine infection has been conventionally sug-
gested to ascend from the lower genital tract; however, F. nucleatum presents a surprising alternative in that 
it is absent in the normal vaginal flora and instead is ubiquitous in the oral cavity frequently associated with 
periodontal disease (1, 8, 9). We have previously reported that F. nucleatum from the subgingival plaque 
likely translocates to the fetoplacental unit through hematogenous transmission as a result of  transient den-
tal bacteremia (2). With pregnancy-associated gingivitis affecting 30%–100% of  the pregnant population, 
transient dental bacteremia is a frequent event during gestation (10–13). When F. nucleatum was injected 
into the tail veins of  pregnant mice to mimic dental bacteremia, it colonized specifically in the murine pla-
centa; first, it was detected in the venous sinuses or at foci adjacent to the venous sinuses in the decidua, and 
then it spread beyond the decidua to the placental membranes and fetal vessels (13). The bacteria eventually 
spread to the amniotic fluids and fetuses after 2–3 days, resulting in fetal demise. Although F. nucleatum was 
detected in the liver and spleen of  the dam at 6 hours following tail-vein injection, it was cleared after 24 
hours. Thus, F. nucleatum infection was localized within the fetoplacental unit, without causing systemic 
Fusobacterium nucleatum is an oral anaerobe prevalent in intrauterine infection associated 
with a wide spectrum of adverse pregnancy outcomes. We demonstrate here that F. nucleatum 
triggers placental inflammation through maternal, rather than paternal, TLR4-mediated 
signaling. Elimination of TLR4 from maternal endothelial cells alleviated placental inflammation 
and reduced fetal and neonatal death, while elimination of TLR4 in the hematopoietic cells 
had no effect. The placental inflammatory response followed a spatiotemporal pattern, with 
NF-κB activation observed first in the maternal endothelial cells and then in the decidual cells 
surrounding the endothelium, followed by induction of inflammatory cytokines and chemokines. 
Supplementation of pregnant mice with fish oil as a source of omega-3 fatty acids suppressed 
placental inflammation, reduced F. nucleatum proliferation in the placenta, and increased fetal and 
neonatal survival. In vitro analysis illustrates that omega-3 fatty acids inhibit bacterial-induced 
inflammatory responses from human umbilical cord endothelial cells. Our study therefore reveals a 
mechanism by which microbial infections affect pregnancy and identifies a prophylactic therapy to 
protect against intrauterine infections.
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infection (13). This acute infection model is consistent with a previously reported human case of  stillbirth, 
in which F. nucleatum was isolated from the mother’s placenta and as pure culture from the stillborn infant’s 
lung and stomach (2). In both mice and the human case, placental colonization by F. nucleatum was accom-
panied by neutrophil infiltration. In mice lacking TLR4, the fetal death rate was reduced despite bacterial 
colonization, indicating that inflammation was the cause of  fetal demise (14). However, the source of  
inflammation was unknown. In the present study, we examine the source and mechanism of  F. nucleatum–
induced placental inflammation and potential therapy to circumvent such inflammation.
Results
TLR4 mediates placental inflammation caused by F. nucleatum. TLRs play a key role in the host innate immune 
response to infection. LPS, an endotoxin present on the outer membrane of  Gram-negative bacteria, is rec-
ognized by TLR4, which then activates NF-κB to initiate transcription of  proinflammatory molecules (15). 
To investigate the host immune responses to F. nucleatum infection, we injected approximately 107 CFU into 
the tail vein of  pregnant wild-type C57BL/6 and Tlr4–/– mice (to mimic dental bacteremia) on day 16–17 
of  gestation as described previously (14, 16). Using nonpregnant mice, we found that F. nucleatum titers in 
the blood circulation underwent two phases of  killing following tail-vein injection (Supplemental Figure 1; 
supplemental material available online with this article; https://doi.org/10.1172/jci.insight.125436DS1). 
The first phase occurred within the first hour, with the live F. nucleatum titer reducing by 3 logs. The titers 
then remained stable for the next 2 hours, before entering the second (and slower) reduction phase, until 
F. nucleatum was completely eliminated. As shown previously (16), F. nucleatum was evenly disseminated 
to the liver, spleen, and placenta at 6 hours after tail-vein injection, when the titer in the circulation was 
relatively stable at approximately 103 to 104 CFU/ml (Supplemental Figure 1). It has been reported that the 
bacterial titer in the blood can reach 105 CFU/ml in healthy individuals and 106 CFU/ml in periodontitis 
patients, with the mean quantities for F. nucleatum reaching 104 CFU/ml in healthy and 105 CFU/ml in 
diseased individuals (17). Thus, our injection dose was within the biological range. As reported previously, 
F. nucleatum did not persist in the liver or spleen and was cleared after 24 hours; instead, it proliferated spe-
cifically in the placenta (16). A temporal inflammatory activation was observed in the placenta (Figure 1A). 
At 24 hours following injection, a marked increase in the mRNA levels of  the proinflammatory cytokines 
IL-1α (IL1a), TNF-α (Tnfa), and granulocyte-macrophage CSF (Gmcsf/Csf2); chemokine monocyte chemo-
tactic protein 1 (Mcp1/Ccl2) and chemokine ligand 5 (Ccl5/Rantes); and COX-2 (Cox2), an enzyme mediat-
ing prostaglandin production during bacterial infection, was observed in comparison to the saline controls. 
At 48 hours, substantial induction of  IL-1β (IL1b) mRNA, along with continued induction of  Mcp1 and 
Gmcsf, was detected, suggesting a time-dependent exacerbation of  inflammation (Figure 1A). IL-12 (IL12), 
IL-18 (IL18), IL-6 (IL6), keratinocyte chemoattractant (KC/CXCL1), leukemia inhibitory factor (LIF), and 
hypoxia-inducible factor 1-α (HIF1a) were tested but not significantly induced in either wild-type or TLR4–/– 
mice (Supplemental Figure 2). H&E staining of  the placenta showed tissue necrosis and neutrophil infil-
tration in the infected placenta at 48 hours after injection but not in the uninfected controls (Figure 1, B 
and C). The protein levels of  IL-1β in the infected placentas were also markedly increased, as shown by 
immunohistochemical staining (Figure 1, D and E). In contrast, in Tlr4–/– pregnant mice, no induction of  
inflammatory cytokines and chemokines was detected, even after 48 hours of  injection of  F. nucleatum 
(Figure 1A). These results demonstrate that induction of  TLR4-mediated inflammatory responses precedes 
fetal death, which occurs after 48–72 hours following F. nucleatum injection (16).
F. nucleatum–induced placental inflammation originates from the maternal endothelial cells. The placenta con-
sists of  cells derived from both maternal (decidua and maternal blood vessels) and fetal (cytotrophoblasts, 
syncytiotrophoblasts, and fetal blood vessels) origins (18). To further dissect TLR4-mediated inflammation, 
Tlr4+/– chimeric placentas were generated by mating wild-type C57BL/6 (Tlr4+/+) and Tlr4–/– parents, fol-
lowed by F. nucleatum infection. The fetal and neonatal death rates of  Tlr4+/+ dams and Tlr4–/– sires were 
similar to those whose parents were both Tlr4+/+ (Figure 2A). In contrast, the death rates were substantially 
lower in Tlr4–/– dams, regardless of  the paternal genotypes (Figure 2A). Consistent with the birth outcomes, 
the expression levels of  inflammatory cytokines and chemokines were markedly induced in placentas from 
Tlr4+/+, but not Tlr4–/–, dams, regardless of  the paternal genotypes (Figure 2, B and C). These observations 
support that fetal and neonatal death results from placental inflammation of  the maternal origin.
Hematopoietic and endothelial cells express various pattern recognition receptors, such as TLRs, 
and are active responders to hematogenous infections. To identify the maternal cell type(s) that elicit the 
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inflammatory responses to F. nucleatum, two Cre-LoxP mouse strains were constructed: Vav1-iCre;Tlr4fl/fl, 
with Tlr4 deleted in 100% of  hematopoietic cells (19), and Tie2Cre;Tlr4fl/fl, with Tlr4 deleted in 80% of  
hematopoietic and 100% of  endothelial cells (20, 21). In comparison to the control group of Tlr4fl/fl mice, 
which were equivalent to Tlr4+/+ mice, fetal and neonatal death rates following F. nucleatum infection were 
significantly reduced in Tie2-Cre;Tlr4fl/fl mice, whereas no difference was detected in Vav1-iCre;Tlr4fl/fl mice 
(Figure 2A). Furthermore, the mRNA levels of  inflammatory cytokines and chemokines were significant-
ly reduced in F. nucleatum–infected Tie2-Cre;Tlr4fl/fl placentas but not in Vav1-iCre;Tlr4fl/fl placentas (Figure 
2B). These results suggest that TLR4 in the endothelial cells is critical for causing placental inflammation 
and fetal and neonatal demise.
To confirm this finding, we performed immunohistochemical analysis to examine NF-κB activation in 
the decidua. As soon as 30 minutes after injection, nuclei translocation of  the immunoreactive p65 subunit 
Figure 1. F. nucleatum induces placental inflammation through TLR4. On day 16 or 17 of gestation, each C57BL/6 wild-type or TLR4–/– mouse received 
approximately 107 CFU of F. nucleatum 12230 or saline. (A) At 24 or 48 hours after injection, the placentas were collected for RNA extraction. The mRNA 
levels of inflammatory cytokines and chemokines were measured by real-time quantitative PCR and are expressed as fold change compared to the 
saline-injected control group. At least 4 pregnant mice were included in each group. The results are presented as dot plots with average and SEM. Two-way 
ANOVA was performed with simple-effects analysis when the interaction was significant. Student-Newman-Keuls was applied for post-hoc comparisons. 
*P < 0.05, **P < 0.01. (B–E) H&E staining (B and C) and immunohistochemical staining of IL-1β (D and E) in the decidua of wild-type mice at 48 hours after 
injection with saline (B and D) or approximately 107 CFU of F. nucleatum (C and E). Original magnification, ×100 (B and C); ×500 (D and E); zoom, 3-fold 
from ×100 image (insets). Representative image from 4 placentas from 2 dams of each group was selected.
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of  NF-κB (also known as RelA) was detected in the decidual endothelial cells of  the wild-type, Tlr4fl/fl, and 
Vav1-iCre;Tlr4fl/fl placentas (Figure 3, A, D, and F). After 2 hours, p65 was no longer detected in the endo-
thelial nuclei but was instead in the nuclei of  the surrounding cells (Figure 3, G and I). No nuclear translo-
cation of  p65 was detected in the saline control or F. nucleatum–infected Tlr4–/– or Tie2-Cre;Tlr4fl/fl placentas 
Figure 2. F. nucleatum–induced placental inflammation originates from the maternal 
endothelial cells. Approximately 107 CFU F. nucleatum 12230 or saline was injected 
into the tail vein of each C57BL/6 pregnant dam on day 16 or 17 of gestation. (A) The 
fetal and neonatal death rate was calculated as the percentage of dead fetuses and 
neonates per litter at birth and followed up to 3 days after birth. Genotypes of the 
mating parents are shown below the x axis. Each geometric symbol represents 1 preg-
nant mouse. The horizontal lines indicate the average death rates. (B) mRNA levels in 
the placentas measured by real-time quantitative PCR and expressed as fold changes 
compared with each genotypes’ own saline-injected control groups. At least 3 pregnant 
dams were included in each group. (C) Protein levels of IL-1β in the placentas, as deter-
mined by ELISA. At least 3 pregnant dams were included in each group. For B and C, 
the placentas were collected at 48 hours after injection and pooled for each pregnant 
dam. The results are presented as dot plots with average and SEM. Two-way ANOVA 
was performed with simple-effects analysis when the interaction was significant. 
Student-Newman-Keuls was applied for post-hoc comparisons. *P < 0.05, **P < 0.01, 
***P < 0.001. D, Dam; S, Sire.
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(Figure 3, B, C, E, and H), demonstrating that the decidual endothelial TLR4 plays a critical role in NF-κB 
activation. We therefore conclude that placental inflammation originates from the maternal endothelial 
cells in this model. Combining the results from Figure 1 and Figure 3, a spatiotemporal pattern of  the pla-
cental inflammation has emerged, i.e., sequential NF-κB activation in the decidua precedes production of  
inflammatory cytokines and chemokines.
Dietary omega-3 fatty acids suppress F. nucleatum–induced placental inflammation and protect fetuses. Dietary 
supplementation of  omega-3 polyunsaturated fatty acids in the form of  fish oil has been widely used to 
reduce inflammation in chronic inflammatory diseases, such as cardiovascular disease and rheumatoid 
arthritis, and has been safely recommended for use during pregnancy (22–29). Humans consuming a diet 
rich in fish oil have been shown to harbor increased quantities of  omega-3 fatty acids, such as eicosapen-
taenoic acid (EPA) and docosahexaenoic acid (DHA), in their cellular phospholipid membranes (30) and 
in breast milk (31). Increase in omega-3 fatty acids in the cellular composition has been associated with 
antiinflammatory and immunosuppressive properties, although the extent and the mechanism of  immune 
Figure 3. F. nucleatuminduces nuclear translocation of the p65 subunit of NF-κB in the decidua. Immunohistochemical staining of the p65 subunit of NF-κB 
in the decidua of wild-type C57BL/6 (A, B, and G), Tlr4–/– (C), Tlr4f/f (D), Tie2-Cre;Tlr4f/f (E and H), and Vav1-iCre;Tlr4f/f (F and I) mice at 30 minutes (A–F) and 2 
hours (G–I) after injection with saline (B) or approximately 107 CFU F. nucleatum (A, C, and D–I). Immunoreactive p65 was detected in the endothelial nuclei in 
A, D, and F and in the cells surrounding the venous sinuses (V) in G and I (insets). No nuclear p65 was detected in B, C, E, or H. Original magnification, ×500; 
zoom, 3.5- to 5-fold (insets). Representative image of at least 3 placentas from 1–2 dams of each group was selected.
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modulation may vary depending on the nature of  fatty acids, source of  infection and inflammation, and 
infected tissue or cell types (22, 32–37).
To determine their antiinflammatory effects in endothelial cells, purified omega-3 fatty acids, EPA 
(20:5n-3) and DHA (22:6n-3), mixed at 3:1, were preincubated with primary cultures of  human umbilical 
vein endothelial cells (HUVECs) prior to addition of  F. nucleatum. A common omega-6 fatty acid, arachi-
donic acid (20:4n-6), was tested as a control. The mRNA expression levels of  MCP1, IL8, CCL5, IL1β, and 
IL6 and the endothelial activation markers intercellular adhesion molecule 1 (ICAM1) and E selectin were 
induced by F. nucleatum but the induction was substantially suppressed in cells preincubated with omega-3 
fatty acids in a dose-dependent manner (Figure 4). In contrast, only a few inflammatory markers were 
inhibited by omega-6 fatty acids, even at the maximum dose tested (Figure 4).
For in vivo testing, pregnant mice were orally gavaged with fish oil as a source of  omega-3 fatty acids 
throughout the gestation until they were injected with F. nucleatum. The fetal and neonatal death rate was 
markedly reduced in C57BL/6 mice fed with 33 mg omega-3 fatty acids compared with the water-gavaged 
controls (Figure 5A). The supplementation did not affect the maternal body weight (Supplemental Figure 
3). In order to determine if  the observed fetal and neonatal protection was specific to C57BL/6 mice, and 
because humans are outbred, the outbred CF-1 mice were also tested. Similar results were obtained, and a 
dose-dependent pattern was observed. A trend of  fetal and neonatal death reduction was detected at a lower 
dose of  3 mg omega-3 fatty acids, which reached significance at a higher dose of  16 mg (Figure 5C). Placental 
inflammation was suppressed by omega-3 fatty acids in both C57BL/6 and CF-1 mice, as shown by real-time 
qPCR analysis of  inflammatory molecules at 48 hours after F. nucleatum injection (Figure 5, B and D).
Surprisingly, omega-3 fatty acids also suppressed F. nucleatum proliferation in the placenta. In both 
C57BL/6 and CF-1 mice, the live bacterial titers increased with time in the control placentas, consistent 
with a previous report (16); however, they remained stagnant in C57BL/6 placentas and decreased in CF-1 
placentas following supplementation with omega-3 fatty acids (Figure 5, E and F). Bacteriostatic prop-
erties of  omega-3 fatty acids have been reported for Helicobacter pylori, both in vitro and in vivo (38–40), 
suggesting omega-3 fatty acids as potential preventives for H. pylori–associated gastric diseases. However, 
for F. nucleatum, in vitro testing showed that omega-3 fatty acids exhibited no bactericidal effects in vitro 
(Supplemental Figure 4). It is likely that the lack of  proliferation is secondary to the suppression of  inflam-
mation due to the possible inflammophilic nature of  F. nucleatum (41). In support of  this possibility are the 
Figure 4. Purified omega-3 fatty acids suppress endothelial inflammation induced by F. nucleatum. Purified omega-3 (300 μM or 600 μM) or omega-6 fatty 
acids (600 μM) were complexed with fatty acid–free BSA at a molar ratio of 4:1 and preincubated with HUVECs for 3 hours prior to bacterial infection. Log-
phase F. nucleatum was incubated with primary HUVECs at an MOI of 50:1 for 24 hours. Levels of mRNA were measured by real-time quantitative PCR and are 
expressed as fold change compared to the uninfected control group. Each experiment was performed in triplicates and repeated at least 3 times. The results 
are presented as dot plots with average and SEM. One-way ANOVA was performed with Bonferroni post-test. **P < 0.01, ***P < 0.001, ****P < 0.0001.
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observations that the immune suppression was detected at 48 hours but the stagnation of  proliferation in 
C57BL/6 was not evident until 72 hours after injection (Figure 5, C and E). In addition, F. nucleatum titers 
in Tlr4–/– placentas exhibited stagnation after 48 hours, with or without fish oil supplementation, further 
supporting that the lack of  inflammation prohibited bacterial proliferation (Supplemental Figure 5).
In order to test if  the effect of  omega-3 fatty acids is specific for F. nucleatum, HUVECs were infected 
with methicillin-resistant Staphylococcus aureus (MRSA), a Gram-positive pathogen and a leading cause of  
health care–associated infections (42). Omega-3 fatty acids more effectively reduced the expression of  all 
inflammatory genes tested than omega-6 fatty acids (Supplemental Figure 6A). To determine if  omega-3 
fatty acids alleviate the inflammatory responses mediated through TLR signaling, we tested expression 
of  inflammatory cytokines and chemokines in primary HUVECs following incubation with purified E. 
coli LPS, a TLR4 agonist, and Pam3CSK, a TLR2 agonist (Supplemental Figure 6B). While both LPS 
and Pam3CSK upregulated expression of  the inflammatory genes, cells preincubated with omega-3 fatty 
acids exhibited markedly lower inflammatory responses to both LPS and Pam3CSK. Omega-6 fatty acids 
showed no inhibitory effect. These results demonstrate that omega-3 fatty acids effectively suppress endo-
thelial inflammation induced by both Gram-negative and Gram-positive microorganisms.
Discussion
Here, we investigate the placental inflammatory response and its effect on pregnancy outcome using F. nuclea-
tum as stimuli. F. nucleatum–induced placental inflammatory response exhibited a spatiotemporal pattern. 
TLR4-dependent activation of  NF-κB was first detected in the decidual endothelial cells and then in the 
neighboring tissues, followed by continuous induction of  proinflammatory cytokines and chemokines. Inhi-
bition of  placental inflammation in mice lacking TLR4 led to protection of  the fetuses, suggesting that the 
TLR4-mediated inflammatory responses are the cause, either direct or indirect, of  fetal and neonatal demise. 
These results contrast with those of  numerous other studies demonstrating TLR4 as playing a protective role 
against bacterial infection (43–48). In fact, TLR4 expression exclusively on endothelial cells has been shown 
to be sufficient to clear systemic E. coli infection in nonpregnant mice (49). The unusual deleterious role of  
TLR4 in placental infection possibly reflects the immunological features at the maternal-fetal interface. It 
appears that placental TLR4, especially the maternal endothelial TLR4, renders the fetoplacental unit highly 
sensitive to inflammatory responses to infectious microorganisms, causing harm rather than protection.
Elimination of  maternal but not paternal TLR4 inhibited placental inflammation. To the best of  our 
knowledge, this is the first demonstration that intrauterine microbial infection triggers inflammation from a 
maternal source. Our study further identified the maternal endothelium as the origin of  inflammation. This 
is consistent with our previous observation that F. nucleatum infection of  the murine placenta is localized 
primarily in the decidua (16), where the maternal blood is perfused into the placenta through spiral arteries 
(50). The endothelial cells play an important role in early modulation of  immune response against infec-
tious microorganisms, marked by increased permeability, leukocyte adherence, and angiogenesis (51). In 
our model of  hematogenous infection, the endothelial cells are understandably the first to come into con-
tact with the pathogen. Elimination of  endothelial TLR4 blocked the downstream placental inflammation 
and protected the fetuses from F. nucleatum infection. This is consistent with our previous observation of  
sequential detection F. nucleatum in the blood vessels and adherence and invasion of  the endothelial cells, 
followed by colonization and proliferation in the decidua of  infected placentas (13).
The amount of  F. nucleatum in the blood of  healthy and periodontal disease patients shows a remarkable 
difference, but the magnitude of  live F. nucleatum colonizing the placenta in clinical setting has not yet been 
Figure 5. Omega-3 fatty acids reduce F. nucleatum–induced fetal and neonatal death, placental inflammation, and bacterial proliferation. Inbred 
C57BL/6 mice and outbred CF-1 mice were gavaged with fish oil, water, or nothing throughout the gestation starting day 1 through day 16 or 17, when 
approximately 107 CFU of F. nucleatum 12230 or saline was injected via tail vein. (A and C) Fetal and neonatal death rates of C57BL/6 (A) and CF-1 
mice (C). Death rates are expressed as the percentage of dead fetus and neonates of each litter at birth and followed through 3 days after birth. Each 
geometric symbol represents 1 pregnant mouse. Treatment is listed below the x axis. The horizontal lines indicate the average death rates, and error 
bars represent SEM. (B and D) Placental inflammatory mRNA gene expression levels in C57BL/6 (B) or CF-1 mice (D) at 48 hours after injection. Gene 
expression is presented as fold change in comparison to the saline-injected controls, with average and SEM. At least 5 pregnant mice were included 
in each group. (E and F) Live F. nucleatum titers in the placentas of C57BL/6 (E) or CF-1 mice (F) at 48 and 72 hours (E) or 24, 48, and 72 hours (F) after 
injection are expressed as log(CFU per gram tissue). At least 3 pregnant mice were included in each group. The results are presented as dot plots, with 
average and SEM. Mann-Whitney test (A) or 2-way ANOVA (B–F) was performed with simple-effects analysis when the interaction was significant. 
Student-Newman-Keuls was applied for post-hoc comparisons. *P < 0.05, **P < 0.01, ***P < 0.001.
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reported (17). In consideration of  literature that suggests F. nucleatum as a commensal microbe in the pla-
centa (52, 53), our study supports that there may be a concentration dependence, or even a threshold, of  the 
bacterial load in the placenta in causing placental inflammation. This is consistent with our previous report 
that F. nucleatum–induced murine fetal death rate was dose dependent. At an injection dose of  4 × 105 CFU, 
the fetal death rate was merely 6% (16). It is plausible that at low doses F. nucleatum either do not colonize or 
colonize at a very low level without inducing inflammatory responses. Supplementation with omega-3 fatty 
acids appears to keep the titer of  F. nucleatum below that required for activation of  inflammatory responses, 
thus protecting the fetuses.
Having identified the inflammatory origin allowed us to develop intervention therapies. Benefits of  
omega-3 fatty acids and their metabolites have been studied extensively in infectious diseases (54–60). Our 
results show that purified omega-3 fatty acids EPA and DHA suppress inflammatory responses in endothe-
lial cells mediated by both TLR2 and TLR4 and protect against inflammation caused by both Gram-posi-
tive and Gram-negative bacteria in vitro. EPA and DHA are precursors of  proresolving lipid mediators and 
low-inflammatory eicosanoids whose functions include inhibition of  trans-endothelial neutrophil migra-
tion, promotion of  macrophage clearance of  apoptotic neutrophils, and activation of  antiinflammatory 
cytokines and adhesion molecules (61–67). A large body of  literature has demonstrated the antiinflamma-
tory properties of  omega-3 fatty acids (68–71); nonetheless, some clinical trials of  dietary supplementation 
of  omega-3 fatty acids have shown no effect (35, 36, 72). Many supplementation studies have only tested 
modest doses. However, the present study and other successful human trials suggest that doses higher than 
currently recommended may be necessary for special conditions (27, 73–77).
Besides suppression of  inflammation, omega-3 fatty acids also inhibited F. nucleatum proliferation 
in the placenta, which appeared to be secondary to the immune suppression. This is likely due to the 
inflammophilic nature of  F. nucleatum. Previous studies have reported that periodontal pathogens, e.g., 
Porphyromonas gingivalis, are inflammophilic in that inflammation generates a favorable environment for 
its proliferation due to an abundance of  degraded proteins and enrichment of  nutrient-rich exudates 
(78). F. nucleatum is a strong immune stimulator (79–82), consistent with the inflammophilic character-
istics. Fetal protection may be a result of  immune suppression alone or in combination with inhibition 
of  bacterial proliferation. Regardless, this proof-of-concept study opens a wide door for developing ther-
apies to prevent APOs induced by F. nucleatum and possibly other microorganisms that cause localized 
intrauterine infections.
The notion that omega-3 fatty acids may protect against bacterial infection during pregnancy is very 
exciting, especially because there are no safe prophylactic therapies currently available. Given that intra-
uterine infection may occur at any point during pregnancy, continuous use of  antibiotics for preventive 
purpose is impractical. Dietary supplementation of  omega-3 fatty acids has been recommended for preg-
nant women for its benefits in maternal depression, fetal growth, and childhood neurologic and immune 
development (83–85). Our results suggest that it may protect against APO. Previous studies suggest that a 
variety of  oral bacteria may colonize the placenta through hematogenous translocation (1, 52, 86). Our 
study demonstrates that omega-3 fatty acids suppress endothelial inflammatory responses caused by both 
Gram-positive and Gram-negative bacteria. Future studies should examine the effects of  omega-3 fatty 
acids in reducing APOs caused by different inflammatory stimuli.
Methods
Bacterial and mouse strains. F. nucleatum 12230 was maintained as previously described (87). S. aureus LAC 
USA300 CA-MRSA was obtained from Alice Prince (Columbia University, New York, New York, USA) 
and grown in Lysogeny Broth (BD) or on Tryptic Soy Agar plates (BD). CF-1 wild-type mice were pur-
chased from National Cancer Institute Mouse Repository or Charles River Laboratories. C57BL/6 wild-
type mice were purchased from The Jackson Laboratory and bred in-house. Tie2-Cre (20) and Vav1-iCre (19) 
mice were gifts of  Lei Ding (Columbia University). Tlr4–/– mice (88) were obtained from Robert Schwabe 
(Columbia University). Tlr4fl/fl mice (89) were obtained from David Hackam (Johns Hopkins University, 
Baltimore, Maryland, USA). All mice were kept in sterilized filtered-topped cages with a 12-hour light 
cycle, fed autoclaved food (PicoLab Mouse Diet 20 5058; 22 kcal% fat, 55 kcal% carbohydrate, and 23 
kcal% protein) and water ad libitum, and handled in a laminar flow hood.
Mating, fish oil administration, and i.v. injection of  mice. Mating was conducted as previously described (16). 
Briefly, mice were caged together at a female-to-male ratio of 2:1. Mating was determined by the presence of  
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a white vaginal plug. The day when the plug was detected was termed day 1 
of gestation. Mice were randomly distributed to study groups. The omega-3 
group received 3, 16, or 33 mg omega-3 fatty acids from commercial fish oil 
every other day (for C57BL/6) or every day (for CF-1) from day 1 to day 16 of  
gestation by oral gavage. The gavage schedule was determined through consul-
tation with the vet. The control group received an equal volume of sterilized 
water (C57BL/6) or nothing (CF-1). Pregnant mice were injected with approx-
imately 107 CFU of F. nucleatum on day 16 or 17, as described previously (16). 
The death rates of the fetuses and the neonates were recorded up to 3 days after 
birth. For measuring the level of inflammatory response, mice were sacrificed 
at the indicated time after injection, and placentas of each dam were pooled 
and processed for mRNA expression analysis (see Real-time quantitative PCR for 
experimental details). The live bacterial titer was determined from placentas or 
blood collected from tail tips by serial dilutions on blood agar plates. The titer 
was expressed as log CFU/ml of blood or log CFU/g of tissue.
Endothelial cell cultures. Primary cultures of  HUVECs were isolated as 
previously described (90). The cells were maintained at 37°C in 5% CO2 
in complete medium using EGM-2 Bullet Kit (LONZA). HUVECs were 
seeded into 6-well plates coated with rat collagen type I (Corning, 354236) 
and allowed to grow to confluency. For fatty acid treatment, DHA, EPA, 
arachidonic acid, or an equal volume of  absolute ethanol as vehicle control 
were mixed with 1% low-fatty-acid and endotoxin-free BSA (US Biological, 
A1311). Growth medium was replaced with antibiotics-free medium con-
taining indicated concentrations of  the fatty acids or vehicle control for 3 
hours, followed by incubation with F. nucleatum 12230, ultra-pure LPS from 
E. coli 0111:B4 (Invivogen, tlrl-3pelps), or N-palmitoyl(S)-[2,3-bis(palmitoy-
loxy)-(2, RS)-propyl]-Cys-Ser-Lys4 (Pam3CSK4) (Invivogen, tlrl-pms) for 24 
hours or with S. aureus for 5 hours.
Real-time quantitative PCR. RNA was extracted from HUVECs or mouse 
placental tissues using a Qiagen RNeasy Mini Kit (Qiagen, 74106). The 
quantity and quality of  extracted RNA were measured using a NanoDrop 
ND 1000 spectrophotometer (NanoDrop Technologies). cDNA was syn-
thesized by reverse-transcription PCR using the Superscript IV First-Strand 
Synthesis System (Invitrogen, 18091050) according to the manufacturer’s 
instructions. Real-time quantitative PCR was performed in duplicates, using 
StepOnePlus (Applied Biosystems). Each reaction was prepared with the 
Power SYBR Green PCR Master Mix kit according to the manufacturer’s 
instructions (Applied Biosystems). Specific forward and reverse primers 
(Table 1) were used at a concentration of  500 nM. PCR amplifications were 
performed with 40 cycles of  95°C for 30 seconds, 59°C for 30 seconds, and 
72°C for 30 seconds. The results were expressed as 2–ΔCt, where ΔCt is the dif-
ference between the mean Ct value of  the targeted gene and the endogenous 
GAPDH or β-actin control. The fold change was calculated in comparison 
to the saline, PBS, or vehicle-treated control groups.
Immunohistochemistry. Mouse placentas were fixed in 4% paraformalde-
hyde, dehydrated in ethanol, and embedded in paraffin. Tissue sections of 3 
μm were placed on electro-charged slides and heated in a 60°C oven for 1 hour, 
deparaffinized in xylene, and rehydrated sequentially in 100%, 95%, and 75% ethanol and water. Antigen 
retrieval was performed in low-pH solution (Dako Omnis) for 30 minutes at 98°C. After washing in tap water, 
endogenous peroxidase was quenched in 3% hydrogen peroxide, followed by cell permeabilization in 0.3% Tri-
ton X-100. Slides were incubated with 10% horse serum and 0.05% Tween 20 for 30 minutes, followed by rab-
bit anti–IL-1β antibody (Abcam, ab9722), rabbit anti–NF-κB p65 subunit antibody (Cell Signaling Technology, 
CST8242), or rabbit IgG isotype control for 2 hours at room temperature. After washes, slides were incubated 
with ImmPRESS HRP anti-rabbit IgG (Vector Lab) for 30 minutes at room temperature. Slides were developed 
Table 1. Primers used in this study
m β-Actin F: CARCCGTAAAGACCTCTATGCCAAC
R: ATGGGAGCCACCGATCCACA
m KC F: GCTGGGATTCACCTCAAGAA
R: TGGGGACACCTTTTAGCATC
m ICAM1 F: GTGATGCTCAGGTATCCATCCA
R: CACAGTTCTCAAAGCACAGCG
m RANTES F: TGCCCACGTCAAGGAGTATTTC
R: AACCCACTTCTTCTCTGGGTTG
m IL-1α F: ATCAGTACCTCACGGCTGC
R: TGGGTATCTCAGGCATCTCC
m IL-1β F: GAGCACCTTCTTTCCCTTCATCT
R: GATATTCTGTCCATTGAGGTGGA
m IL-6 F: TCCAGTTGCCTTCTTGGGAC
R: GTGTAATTAAGCCTCCGACCTG
m MCP1 F: GCATCCACGTGTTGGCTCA
R: CTCCAGCCTACTCATTGGGATCA
m COX2 F: CAGACAGATTGCTGGCCGGGTTGC
R: GGAGAAGCGTTTGCGGTACTCATT
m IL-12 p35 F: AGTTTGGCCAGGGTCATTCC
R: TCTCTGGCCCTCTTCACCAT
m IL-18 F: CAAGGAATTGTCTCCCAGTGC
R: CAGCCGCTTTAGCAGCCA
m LIF F: AATGCCACCTGTGCCATACG
R: CAACTTGGTCTTCTCTGTCCCG
m HIF1α F: TGCTCATCAGTTGCCACTTC
R: CTTCCACGTTGCTGACTTGA
m GMCSF F: ATGCCTGTCACGTTGAATGAAG
R: GCGGGTCTGCACACATGTTA
m TNF-α F: CAGAGGGAAGAGTTCCCCAG
R: CCTTGGTCTGGTAGGAGACG
h GAPDH F: TGCACCACCAACTGCTTAG
R: GATGCAGGGATGATGTTC
h MCP1 F: AGCAAGTGTCCCAAAGAAGC
R: TGGAATCCTGAACCCACTTC
h IL-8 F: GACATACTCCAAACCTTTCCACC
R: AACTTCTCCACAACCCTCTGC
h IL-1β F: AAGGCGGCCAGGATATAACT
R: CCCTAGGGATTGAGTCCACA
h IL-6 F: CAAATTCGGTACATCCTCGAC
R: GTCAGGGGTGGTTATTGCATC
h RANTES F: GCTGTCATCCTCATTGCTACTG
R: TGGTGTAGAAATACTCCTTGATGTG
h ICAM1 F: ACCATCTACAGCTTTCCGGC
R: CAATCCCTCTCGTCCAGTCG
h E selectin F: AAGGCTTCATGTTGCAGGGA
R: AGCATCGCATCTCACAGCTT
m, mouse; h, human; F, forward; R, reverse. 
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with the DAB Peroxidase Substrate Kit (Vector Lab) and counterstained with 20% hematoxylin followed by 
1% ammonium hydroxide.
ELISA. Placental tissues (50 mg) were homogenized in 500 μl tissue extraction reagent I (Invitrogen, 
FNN0071) with 5 μl protease inhibitor (Thermo) and 1% Triton (Invitrogen). Total protein concentrations 
in the supernatants were measured using the BCA kit. IL-1β was measured by ELISA Antibody Pair (Invi-
trogen, CMC0813) according to the manufacture’s protocol.
Statistics. All results are expressed as the mean ± SEM. Nonparametric Kruskal-Wallis test with Conover 
post-test was used for comparison of  fetal and neonatal death rates (InfoStat version 2014, Córdoba Univer-
sity, Córdoba, Argentina). One-way ANOVA with Bonferroni post-test or two-way ANOVA with simple-ef-
fects analysis and Student-Newman-Keuls post-test were used for group comparisons (GraphPad Prism 5.00 
for Windows). All tests were 2 sided, and a P values of  less than 0.05 were considered statistically significant.
Study approval. This study has been approved by the Institutional Animal Care and Use Committee at 
Columbia University.
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